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Introduction 
 
The ability of light to traverse various chemical and biological barriers and be 
modulated by time and amplitude makes light- regulated molecules unique tools 
for a plethora of applications in the areas of chemistry and biology and 
biomaterials. Photo-removable protecting groups, also known as caging groups, 
are one of the most important light-regulated tools, which can be utilized to mask 
specific functional groups in molecules such that they can be cleaved on demand 
upon irradiation. In biological applications, this typically involves masking a 
biomolecule with a caging group to produce a compound whose biological activity 
is either increased or decreased upon uncaging. The recent development of two-
photon-sensitive protecting groups, which allow uncaging using near-infrared 
(near-IR) irradiation, has resulted in significant improvements in the spatiotemporal 
resolution of uncaging as well as increased penetration with lower photo-toxicity; 
the latter attribute is of particular importance for the use of caged molecules in 
tissue samples or intact organisms that are essentially opaque to UV light. 
Additionally, two-photon un- caging approaches have proved to be extremely 
useful for creating novel biomaterials; in that strategy, laser irradiation is used to 
unmask a specific caged functionality pre-incorporated into a hydrogel or matrix, 
such that it can be used to immobilize peptides, proteins or cells in a three 
dimensionally controlled fashion. 
Differences in the chemical reactivity of various functional groups means that there 
is no single protecting group that can be universally employed for caging 
applications. Sulfydryl-containing compounds play critical roles in various aspects 
of cellular function. Hence, significant effort has gone into development of photo-
activatable thiol-containing peptides or small molecule substrates as tools to 
elucidate or dissect cellular pathways; under many conditions, thiols are the most 
reactive nucleophiles present in biological systems. Importantly, they are prone to 
oxidation and are also relatively poor leaving groups compared with phosphates 
and carboxylates. Those features render the design of photoremovable thiol 
protecting groups challenging.  
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Ortho-Nitrobenzyl (ONB) compounds are the most commonly used caging groups 
for sulfhydryl-protection. ONB groups provide free thiols in high yield upon 
photolysis, however, they are poor chromophores and they generally lack two-
photon sensitivity. To address these limitations, several research groups have 
used coumarin-based protecting groups (e.g., brominated hydroxycoumarin, Bhc) 
for caging applications, due to their high one- and two-photon sensitivity.  
In this work, we analyzed the photolysis of several Bhc-protected thiol-containing 
peptides and small molecules. Those experiments revealed that Bhc-caged thiols 
exhibit variable uncaging yields and that their photolysis frequently leads to the 
formation of an unwanted rearrangement product.  
To circumvent this problem, we explored and designed two alternative highly 
efficient thiol caging groups that can be uncaged upon one- and two-photon 
irradiation. we initially explored using nitrodibenzofuran (NDBF) as a thiol caging 
group. Cysteine-containing peptides were prepared where the thiol was protected 
with an NDBF group. To probe the utility of this protecting group for biological 
experiments, thiol group uncaging was carried out using a K-Ras-derived peptide 
containing an NDBF-protected cysteine. Irradiation of that molecule in the 
presence of protein farnesyltransferase (PFTase) and farnesyl diphosphate (FPP) 
resulted in the formation of the free thiol form and subsequent enzymatic 
conversion to a prenylated species. In order to illustrate the utility of this strategy 
for the development of caged peptides that can be activated via irradiation inside 
live cells, the thiol of a cell-penetrating peptide known to be a substrate for 
palmitoyl acyltransferase was protected as a NDBF thioether. Irradiation of human 
ovarian carcinoma (SKOV3) cells, preincubated with the probe, resulted in 
migration of the peptide from the cytosol/Golgi to the plasma membrane (visualized 
via confocal microscopy) due to enzymatic palmitoylation. These data suggest that 
the NDBF group should be useful for caging thiols in peptides and potentially larger 
proteins assembled via native chemical ligation for biological applications.  
As another approach, guided by mechanistic studies of the photo-triggered 
isomerization of Bhc-thiols, we developed 6-bromo-7- hydroxy-3-methylcoumarin-
ix 
 
4-ylmethyl (mBhc) as an alternative coumarin-based caging group that can afford 
efficient thiol release upon one- and two-photon irradiation. To test the efficiency 
of mBhc for thiol-protection in peptides, we have synthesized a K-Ras-derived 
peptide where the thiol was protected by mBhc. One- and two-photon photolysis 
of the caged peptide resulted in clean conversion to the free compound with no 
photo-isomerization. Irradiation of the caged peptide using a near-IR laser in the 
presence of an enzyme (protein farnesyltransferase, PFTase) resulted in the 
generation of a free thiol-containing peptide which was then enzymatically 
farnesylated.  
To further evaluate the utility of this novel caging group for biomaterial applications, 
an mBhc-protected thiol was covalently incorporated into a hydrogel. Using a 740 
nm two- photon laser from a confocal microscope, patterns of free thiols were 
generated inside the matrix and visualized by reaction with maleimide 
functionalized fluorophores. Such 3D patterns could be useful for a variety of 
applications in tissue engineering. Such highly tuned matrices allow artificial 
extracellular environments to be created that can be used to study cell migration, 
differentiation and cell–cell interactions. 
Lastly, we strived to develop a novel NDBF-based caging group with red-shifted 
absorption maxima and improved two-photon uncaging efficiency. Inspired by 
previous studies, we elected to modify the structure of NDBF by adding an amine 
as a donor group, to generate a donor-acceptor system. Hence, 2-bromo-2-(7-
(dimethylamino)-3-nitrodibenzofuran-2-yl)acetate was synthesized in 9-steps. 
Initial analysis of spectral properties of the designed molecule showed the 
absorption maxima (λmax) to be 440 nm. This is110 nm red-shifted relative to 
λmax of NDBF. The uncaging efficiency of this novel protecting group remains to 
be tested.  
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1 Photo-cleavable protecting groups for thiols: 
Synthesis, biological and biomaterial applications 
 
1.1 Introduction 
Photo-cleavable protecting groups, or caging groups, have been increasingly 
utilized in organic synthesis1, cell biology2–5 and biomaterials as a mean for spatio-
temporal release of chemicals as well as biomolecules inside living systems.6,7,8 
Covalent attachment of the caging group to a key functionality in the bioactive 
agent renders the molecule inactive. Subsequent irradiation leads to cleavage of 
the protecting group, thus resulting in on-demand and localized release of the 
active moiety. Although providing enough energy for uncaging generally requires 
high energy ultra-violet (UV) irradiation, recent advances in two-photon cleavable 
protecting groups have improved the biocompatibility of this technique by using 
near infra-red light for uncaging.9–11 This significantly extends the applicability of 
caging technique by improving spatial resolution, tissue penetration as well as 
eliminating photo-toxicity.  
A variety of photo-cleavable protecting groups have been developed for caging of 
various functionalities. Alcohols and carboxyl groups are among the most studied 
functionalities for caging.4 However, due to differential chemical reactivity and 
variations in local chemical environments, there is no single protecting group that 
can be universally employed for caging applications. 1,4,9 
Efficient caging of thiols is particularly desirable because of their abundance as 
cysteine residues and cofactors in biological systems. Furthermore, thiols share a 
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significant role in various aspects of biology including signal transduction, 
apoptosis, enzymology, controlling cellular redox state and cellular defense 
system.12–14 Therefore, significant efforts have gone into developingcaging groups 
for thiol sulfhydryls14 in order to create photo-activatable probes,15–17 biomaterials 
for dissecting cellular pathways,18 and orthogonal protecting group for the 
synthesis of complex thiol-containing biomolecules.19,20 Several properties of thiol 
reactivity render the design of photo-removable thiol protecting groups challenging 
and must be considered. Thiols are among the most reactive functionalities 
present in biological systems. They are prone to oxidation, undergo nucleophilic 
reactions and also react with free radicals. Importantly, thiols are relatively poor 
leaving groups compared to alcohols and carboxylates.  
The present review summarizes current developments in thiol caging groups and 
their applications in peptide and protein synthesis, cell biology and biomaterial 
development (Figure 1-1).  
 
Figure 1-1 An overview of various photo-removable protecting groups that have 
been used for sulfhydryl protection. (1) ortho-nitrobenzyl (ONB) derivatives, (2) 
coumarin derivatives, (3) nitrodibenzofuran (NDBF), (4) para-hydroxyphenacyl 
(pHP), (5) 2-Benzoylbenzoic acid.  
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1.2 Ortho-nitrobenzyl based caging groups 
Ortho-nitrobenzyl (ONB) derivatives were initially developed and used as 
orthogonal protecting groups in organic synthesis. The first application in 
biochemistry was reported by Kaplan et. al. in 1978, with the synthesis of “caged 
ATP”.21 Since then, they have found numerous applications in a variety of 
biological studies ranking them the most commonly used photo-labile protecting 
groups.22 ONB-derivatives have been utilized in a variety of caged biomolecules, 
many of which are commercially available. The general advantages of ONBs are 
their ease of synthesis, high yield of conversion to the uncaged product and 
modest one-photon quantum efficiency. However, ONBs have comparatively low 
absorptivity and two-photon efficiency, which limits their applicability for studies 
where deeper tissue or matrix penetration is needed. 
ONBs are also the most widely employed approach for thiol protection (Figure 1-
2). Multiple research groups have employed ONBs for masking critical cysteine 
residues during the synthesis of peptides as well as protein ligations.  
 
Figure 1-2 An overview of various ONB-based photo-removable protecting 
groups that have been used for sulfhydryl protection. 
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Since, protein ligations are performed in aqueous solutions, water soluble ONB-
derived α-carboxy-2-nitrobenzyl (CNB, 7) and α-carboxy-4,5-dimethoxy-2-
nitrobenzyl (CDMNB, 9) have been developed for cysteine protection. Hagen and 
coworkers studied photolysis properties of CNB- and CDMNB-protected cysteines 
in peptides (Figure 1-3).23 It had been previously reported that presence of amines 
enhances photo-decarboxylation instead of photo-release, therefore, photolysis 
experiments were carried out in both amine-free PBS or amine-enriched HEPES 
buffers, and also photolysis of both N-terminal acylated and free N-terminal 
peptides were studied. Photolysis of caged peptides followed by HPLC analysis 
revealed that peptide 11b produced most free peptide (74%) with either zero or 
very low decarboxylation in the PBS and HEPES buffers, respectively. However, 
free N-terminal peptide 10a and 10b produced the most decarboxylated products. 
Although decarboxylation was suppressed in amine-containing buffers, the 
influence of N-terminal amines on elevating decarboxylation was much more 
significant. Further photolysis studies with different caged peptides revealed that 
the extent of decarboxylation is case-sensitive and highly dependent on peptide 
sequence. Generally, these results suggest that CDMNB is superior to CNB for 
thiol protection due to faster photolysis and longer absorption maxima; however, 
appropriate measures should be taken to avoid decarboxylation. The quantum 
yields for peptide 10 and 11 were measured to be 0.04 and 0.07, respectively.  
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Figure 1-3 Structures of model caged peptides utilized by Hagen and coworkers 
to study the photo-chemical properties of CNB and CDMNB when utilized for 
cysteine protection. Figure was adapted and reproduced from Kotzuer et. al. [23].   
 
Muir and coworkers used ONB for cysteine protection during expressed protein 
ligation (EPL).24 In order to study the relationship between ubiquitylation and 
upregulation of lysine methylation in different histones via methyltransferase 
hDotl1. EPL was used for site-specific chemical ubiquitylation of histone H2B 
(Figure 1-4). Two traceless orthogonal ligations were used to synthesize 
ubiquitylated H2B (uH2B). Initially, a caged cysteine-linked polypeptide (117-125, 
A117C mutation, 12) was ligated to recombinant ubiquitin (1-75)-α-thioester 13 
yielding protein 14. The ligated product was irradiated at 365 nm resulted in 
deprotection of the caged cysteine residue to give 15. The obtained free cysteine 
ultimately was employed for ligating 15 to  yield fully ligated uH2B(A117C) 16. 
Desulfurization of 16 resulted in the formation of the desired uH2B protein 18. 
Successful implementation of this strategy revealed ubiquitylation of H2B directly 
activates intranuclesomal methylation of H3 K79 protein via hDot1L.  
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Figure 1-4 Synthetic scheme for ubiquitylation of U2B. The first step includes 
ligation of ONB-caged polypeptide to peptide thioester generating 14. Subsequent 
irradiation of 14 with UV light released the latent cysteine readily utilized for the 
next round of ligation. Second ligation followed by desulfurization resulted in 
formation of ubiquitylated U2B. The figure was adapted and reproduced from 
McGinty et. al. [24]. 
 
In an innovative approach, Otaka and coworkers developed a one-pot/sequential 
native chemical ligation methodology using 4,5-dimethoxy-2-nitrobenzyl (DMNB, 
8, Figure 1-2) photocaged crypto-thioester.20 They had previously shown that C-
terminal N-sulfanylethylanilides (SEAlide) can rearrange to form a thioester upon 
treatment with phosphate, thus readily ligated to a N-terminal cysteinyl peptide 
(Figure 1-5).19 Since, the phosphate could activate any subsequently added 
SEAlide containing peptide, this methodology could not be applied for multi-step 
ligation purposes.  
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Figure 1-5 The mechanism of phosphate-triggered SEAlide activation which is 
readily reactive toward chemical ligation. The figure was adapted and reproduced 
from Aihara et. al. [20]. 
 
To address this problem, they developed a photo-activatable SEAlide moiety. This 
was achieved by caging the sulfhydryl functionality on the SEAlide using DMNB 
protecting group (Figure 1-6). This enables one-pot sequential native chemical 
ligation (NCL) using light as an external trigger This strategy was successfully 
employed in a four-fragment sequential synthesis of 41 amino acid SNX-482 
peptide (29, Figure 1-6), a potent inhibitor for of R-type Ca2+ channels isolated from 
the tarantula Hysterocrates gigas. In the first step, peptides 21 and 22 were ligated 
under standard NCL conditions to yield peptide 24. Before each photolysis step, 
thiophenol was removed via extraction to avoid generation of high energy thiyl 
radicals which could lead to formation of several byproducts. Photolysis of 24 
resulted in deprotection of DMNB group and generated peptide 25. Addition of 
thiophenol together with 23 to the solution containing 25 resulted in formation of 
26. Another round of thiophenol extraction followed by photolysis yielded 27. 
Finally, NCL between 27 and 28 resulted in formation of fully ligated product 29. 
These results demonstrate the utility of combining SEAlide chemistry with thiol 
photo-caging strategies as a powerful tool for sequential and convergent 
syntheses of polypeptides and proteins.   
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Figure 1-6 Strategy developed by Otaka and coworkers for peptide/protein 
synthesis using photocaged SEAlide moiety. The figure was adapted and 
reproduced from Aihara et. al. [20]. 
 
In addition to applications in chemical ligations, ONB deriveshave been used for 
directed disulfide bond formation in peptides. Hossain and coworkers utilized 
DMNB (also referred to as 2-nitroveratryl group) for photo-cleavable thiol 
protection in combination with S-pyridinesulfenyl activation to achieve rapid photo-
triggered generation of disulfide bonds in peptides (Figure 1-7A).25 This strategy 
was successfully employed for the solid phase synthesis of cysteine-rich peptides, 
including oxytocin, α-conotoxin ImI and human insulin. Synthesis of α-conotoxin 
ImI 35 is depicted in Figure 1-7. Initially a Fmoc-Cys(DMNB)OMe residue is 
incorporated into peptide through traditional solid phase peptide synthesis. After 
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isolation of precursor 32, disulfide bond formation was achieved upon treatment 
with dipyridine disulfide (DPDS) to give peptide 33. S-tbu cleavage of 33 followed 
by concomitant S-pyr functionalization yielded peptide 34. Photolysis of 34 at 350 
nm resulted in thiol deprotection and rapid in situ disulfide formation to generate 
desired α-conotoxin ImI. In order to show the utility and versatility of this approach, 
the same procedure was used for synthesis of more complex human insulin.  
 
 
Figure 1-7 A) Reaction mechanism for disulfide bond formation via photocleavage 
of the DMNB group followed by subsequent thiolysis through S-pyridinesulfenyl 
activation. B) This strategy was employed for the synthesis of α- conotoxin. The 
figure was adapted and reproduced from Karas et. al. [25]. 
 
Applications of ONB-derived groups for thiol caging is not limited to peptide or 
protein synthesis. Several reports demonstrated ONBs’ utility in development of 
photo-activatable probes useful for biological investigations. Distefano and 
coworkers utilized CNB group for cysteine protection of peptides that are 
substrates for protein farnesyl transferase (Figure 1-8).26 3H-FPP (farnesyl 
diphosphate) assays which were used to quantify the extent of farnesylation, 
revealed that the caged peptide KKKSKTKC(CNB)VIM was not processed by the 
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protein farnesyltransferase (PFTase). However, irradiation at 365 nm released the 
free peptide which was subsequently processed by PFTase and become 
farnesylated (peptide 37). The uncaging yield was 60% and the quantum yield was 
measured to be 0.16 higher the reported value by Hagen and coworkers. 
 
 
Figure 1-8 A) Schematic representation of the peptide photo-release and 
concomitant farnesylation of the caged peptide. B) Farnesylation of caged peptide 
before and after irradiation quantified via 3H-FPP assays. The figure was adapted 
from Degraw et. al. [26] and reproduced. 
 
Lawrence and coworkers used CNB for development of a caged protein involving 
in cell signaling pathway.27 Cofilin plays a pivotal role in cell motility through 
polymerization and depolymerization of actin filaments. This enzyme is regulated 
via phosphorylation of Ser-3 residue. However, S3C mutants of cofilin are unable 
to be phosphorylated and thus remain constitutively active. Using CNB on the Cys-
3 thiol, they have created a caged cofilin which, according to in vivo assays shown 
in Figure 1-9, could not depolymerize actin. However, UV irradiation of the caged 
enzyme restored the activity of the mutant enzyme and resulted in actin 
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depolyermization. HPLC assays revealed photolysis of caged cofilin could restore 
90% of its activity. Next, in order to further elaborate the role of cofilin in cell motility, 
the developed photo-activatable protein was injected into cells. Through acute and 
local activation of the caged enzyme via irradiation, they demonstrated that cofilin 
polymerizes actin, generates protrusions and determines the direction of cell 
migration.28 
 
Figure 1-9 (A) Synthesis of caged cofilin mutant, B) Rhodamine-labeled F-actin 
filaments are not cleaved by caged cofilin, (C) 15 min UV photolysis released the 
mutant enzyme resulted in actin depolymerization. Cleavage sites are shown by 
arrows. The figure was adapted from Ghosh et. al. [27] and reproduced. 
 
Bayley and coworkers utilized ONB, CNB, DMNB groups for caging a critical 
cysteine residue in the catalytic subunit of cAMP-dependent protein kinase 
(PKA).29 They compared the efficiency of each caging group toward deactivation 
of PKA as well as their ability to restore the enzymatic activity upon UV irradiation 
and photo-cleavage. In this case, ONB was the best caging group, since not only 
12 
 
did the ONB-protected PKA show the least residual activity, but also protein activity 
was restored to the highest degree upon irradiation. ONB-caged PKA showed 20-
30 fold increase in protein activity upon photolysis, making it useful for biological 
experiments. Photolysis of CNB- and DMNB-caged PKA, however, resulted in only 
2-3 fold increase in activity. They also studied the effect of pH on uncaging 
efficiency of ONB. Analysis of photolysis reactions at different pHs revealed that 
the uncaging is significantly more efficient under slightly acidic (pH 6) relative to 
slightly basic conditions (pH 8.5). The quantum yield was measured to be 0.84 in 
acidic conditions which is significantly larger than that of basic ones which was 
measured to be 0.14. 
As an alternative to chemical methods for protein caging, Schultz and coworkers 
for the first time used unnatural amino acid incorporation technique to genetically 
incorporate caged cysteine into different proteins (Figure 1-10).30 They generated 
a new orthogonal Escherichia coli tRNALeu/leucyl tRNA-synthetase pair that was 
used to selectively incorporate caged ONB-cysteine 40 into protein in yeast in 
response to amber nonsense codon TAG. This strategy was used to generate a 
caged cysteine protease, caspase 3. The activity of the caged enzyme was 
measured in cell lysates before and after 10 min UV irradiation. In vitro enzymatic 
assays revealed that 40% of the caged caspase was converted to the active 
enzyme under aforementioned photolysis conditions.  
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Figure 1-10 (A) Primary sequence of the leucyl suppressor tRNA, Leu5CUA. (B) 
The active site of leucyl tRNA-synthetase is shown with a bound leucyl sulfamoyl 
adenylate inhibitor (green). The residues randomized in generating the synthetase 
library are in yellow. The catalytic domains of synthetase are in pink. (C) Structure 
of o-nitrobenzyl cysteine being incorporated using this tRNA/Synthetase pair. The 
figure was adapted from Wu et. al. [30] and reproduced. 
 
Using the same technique but a different approach, Deiters and coworkers 
engineered the molecular structure of caged cysteine and homocysteine and were 
able to employ an existing M. barkeri pyrrolysine tRNA synthetase (PylRS) mutant 
to express caged protein in bacteria and mammalian cells.31  
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1.3 Coumarin-based caging groups 
 
 
Figure 1-11 An overview of various coumarin-based photo-removable protecting 
groups that have been used for sulfhydryl protection. 
 
Coumarin-based caging groups (Figure 1-11) have generally been used for 
protection of carboxyls and alcohols. Attractive features of coumarins relative to 
their ONB-based counterparts are their high absorptivity at longer wavelengths, 
faster uncaging rate, fluorescent properties, improved solubility and larger two-
photon cross-section However, the application of coumarin-based caging groups 
for thiol protection has only been studied in recent years mostly by Hagen,32 
Distefano16,33,34 and Shoichet35–37 groups.  
Hagen and coworkers developed two water soluble coumarin-based derivatives, 
[7,8-Bis(carboxymethoxy)coumarin-4-yl]methoxycarbonyl] (7,8BCMCMOC, 42, 
Figure 1-11) and [7-[bis(carboxymethyl)amino]coumarin-4-yl]methoxycarbonyl] 
(BCMACMOC, 43, Figure 1-11). These two compounds were utilized for the 
development of caged cysteines. In their design, both of the caged cysteines were 
masked through thio-carbamate linkages(Figure 1-12), and the developed caged 
moieties were incorporated into peptides using solid-phase peptide synthesis. 
Because the light absorption characteristics ofcompounds 42 and 43 are highy 
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differentiable, withλmax of 324 nm and 385 nm, respectively, they were able to be 
irradiated and removed in a wavelength-selective fashion. As shown in Figure 1-
12B, a mixture of 45 and 46 was first photolyzed at 402 nm and subsequently at 
325 nm, and the amount of released cysteine was quantified. As predicted, 
irradiation at 402 nm resulted in deprotection of cysteine 46 while further photolysis 
at 325 nm resulted in the deprotection of the remaining cysteine. However, 
uncaging of 46 at 402 nm and 45 at 325 nm produced cysteine with only 60 and 
40% yield respectively.  
 
Figure 1-12 A) Structures of Fmoc-cysteine protected with coumarin-based 
hydrophilic coumarin-based photo-removable protecting group, B) Wavelength 
selective uncaging of caged cysteines. The figure was adapted from Kotzuer et. 
al. [32] and reproduced. 
 
This wavelength-selective binary system was then used for the synthesis of a 
caged model peptide called resact (50, Figure 1-13). Resact is a 14-mer peptide 
containing two cysteines which is well studied as the sperm attractant in the sea 
urchin Arbacia punctulata. In order to avoid any intramolecular S- to N- acyl shift 
during the solid phase synthesis, Fmoc cleavages were carried out via short 
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treatment with DBU, and the N-terminal amine was also acetylated. As expected, 
photolysis of the caged peptide at 402 nm resulted in selective uncaging of Cys1; 
however, S-acyl transfer from Cys8 to Cys1 resulted in the generation of an 
equimolar mixture of 7,8BCMCMOC-masked Cys1 and Cys8.. Although, 
subsequent irradiation at 325 nm led to the generation of fully deprotected peptide, 
these results reveal limitations in applicability of thiocarbonates for selective thiol 
caging and also cysteine protection in peptides, particularly those with free N-
terminus.  
 
 
Figure 1-13 Two-step wavelength selective photolysis of caged resact. The 
figure was adapted from Kotzuer et. al. [32] and reproduced. 
 
As an alternative to Hagen’s thiocarmbamate-linked thiol protection, Distefano and 
coworkers developed a caged farnesyl transferase inhibitor in which the thiol 
functionality is masked by a bhc (bromohydroxy coumarin) protecting group 
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through direct thioether linkage(Figure 1-14).34 HPLC analysis of photolysis 
experiments revealed that the uncaging yield achieved by one-photon process is 
> 60% and > 40% via two-photon irradiation. The quantum yield was measured to 
be 0.074. Interestingly, LC-MS analysis of the photolyzed mixtures revealed 
generation of a small amount of photo-isomeric byproduct which was attributed to 
S- to N-alkyl shift. The designed caged inhibitor was then used for photo-controlled 
modulation of farnesylation inside different types of cell lines. For example, 
treatment of the caged PFTase inhibitor 53 with fibroblast cells resulted in no 
change in cell morphology in comparison with vehicle treated cells. However, 
exposure of the caged inhibitortreated cells to either one- (365 nm) or two-photon 
(800 nm) irradiation resulted in radical morphological changes similar to cells 
treated with free inhibitor. This experiment was one of the first two-photon triggered 
cellular experiments utilizing caged thiols.  
 
Figure 1-14 Synthesis of caged farnesyl transferase inhibitor 53. 
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Figure 1-15 Morphology of fibroblast ciras-3 cells treated with Bhc-FTI. A) 
Untreated cells, B) treated with 2.5 µM FTI, C) treated with 2.5 µM Bhc-FTI with no 
irradiation, D) treated with 2.5 µM Bhc-FTI followed by 1h two-photon irradiation at 
800 nm. The figure was adapted from Abate et. al. [34] and reproduced. 
 
Shoichet and coworkers for the first time harnessed caged thiols for photo-
patterning purposes in biomedical applications. In their design, bhc protected 
cysteamine moieties were incorporated into hydrogel matrix. Upon irradiation via 
two-photon laser, highly defined volumes of free sulfhydryl groups were generated 
and ultimately used as anchors to immobilize different types of thiol reactive 
biomolecules such as maleimide-linked peptides and proteins (Figure 1-16A).36 As 
an example, they employed this strategy to create three dimensional patterns of 
stem-cell differentiation factors sonic hedgehog (SHH) and ciliary neurotrophic 
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factor (CNTF) inside agarose gel (Figure 1-16 B, C).35 To achieve this, they initially 
used two-photon sulfhydryl uncaging to sequentially immobilize maleimide-
barnase and maleimide-streptavidin. Orthogonal physical binding pairs, barnase-
barstar and streptavidin-biotin, were then employed to immobilize fusion proteins 
barstar–SHH and biotin–CNTF, resulting in highly defined bioactive 3D patterned 
hydrogels. This technique sets the stage for the development of highly defined, 
chemically complex scaffolds, which enables the study of the effect of extracellular 
matrix on cell fate, migration and differentiation.  
 
Figure 1-16 A) Schematic illustration of multi-photon chemical patterning in 
hydrogel incorporating caged thiol moieties, B, C) Representative figures for the 
simultaneous 3D patterning of biotin–CNTF–633 (green) and barstar–SHH–488 
(red). The figures were adapted from [36] and [35]. 
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Despite the reported use of Bhc for successful thiol protection, further studies by 
Distefano and coworkers on caged peptides revealed that the uncaging efficiency 
of Bhc, along with other relevant coumarin-based protected thiols, are significantly 
limited by an unwanted photo-isomeization reaction pathway.16 Thorough 
mechanistic analysis of photolysis of caged small molecules as well as peptides, 
they have demonstrated that the major product of photolysis of Bhc-protected 
thiols is not the free thiol, but rather an isomeric product formed via the two step 
process depicted in Figure 1-17. They have proposed that the first step involves a 
photo-induced 1,3 shift of the thiol from the exocyclic position to the endocyclic 3 
position yielding intermediate 55, which undergoes tautomerization to produce the 
final photo-rearranged product 56. These results demonstrate that coumarin-
based caging groups, and Bhc in particular, are not efficient caging groups for thiol 
protection. 
 
Figure 1-17 Photo-rearrangement mechanism of Bhc protected cysteine. 
 
In an effort to create a more efficient coumarin-based protecting group, Distefano 
and coworkers developed 6-bromo-7-hydroxy-3-methyl coumarin-4-ylmethyl 
(mBhc, 44, Figure 1-11) as a Bhc analogue which yields efficient thiol release upon 
both one- and two-photon photolysis.33 Guided by the mechanism of Bhc photo-
isomerization, they hypothesized that replacing hydrogen at the endocyclic 3 
position with a methyl group would eliminate the photo-isomerization pathway. An 
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analogous intermediate to 55 would be unable to rearomatize, and furthermore, 
unfavorable syn-pentane type steric interactions between the sulfhydryl and 
methyl groups would destabilize the necessary conformation of thiol migration 
(Figure 1-18 A, B). The designed mBhc group was used for thiol protection in 
peptides, and HPLC analysis of photolysis reactions revealed that conversion of 
the mBhc protected peptide to the free peptide proceeded cleanly without any 
byproduct formation due to undesired photoisomerization. Spectral properties of 
mBhc showed minimal alteration relative to those of Bhc. The uncaging quantum 
yield (at 365 nm) and two-photon action cross-section (at 800 nm) of mBhc caged 
thiol was measure to be 0.013 and 0.16 GM, respectively.  
 
 
Figure 1-18 A, B) Illustration of potential effects of C-3 substitution on photo-
isomerization process. C) Uncaging reaction of mBhc-protected peptide. The 
figure was adapted from Mahmoodi et. al. [33] and reproduced. 
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To demonstrate the utility of this new caging group for biomedical application, in 
collaboration with Shoichet’s group, they incorporated mBhc caged cysteamine 
into cross-linked hyaluronic acid hydrogels.33 Using multiphoton irradiation at 800 
nm, they generated highly localized free thiols inside hydrogels which then reacted 
with maleimide-Alexa Fluor creating 3D fluorophore patterns. The photo-patterning 
efficiency of hydrogels incorporating mBhc versus Bhc protected thiols were 
measured by comparing the intensity of immobilized fluorophore upon similar laser 
exposure. As shown in Figure 1-19, the intensity of thiol labeling was 4-fold higher 
in hydrogels prepared using mBhc compared with Bhc due to the greater uncaging 
efficiency of the former. These results demonstrate mBhc as a coumarin-based 
Figure 1-19 Comparison of two-photon patterning using Bhc- and mBhc-caged 
thiol. Uncaging of Bhc or mBhc-conjugated HA hydrogels, and subsequent 
immobilization of Alexa Fluor 546. The figure was adapted from Mahmoodi et. al. 
[33] and reproduced. 
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caging group able to mediate efficient thiol release upon both one- and two-photon 
irradiation and represents a marked improvement over Bhc. 
1.4 Nitrodibenzofuran Cages for Thiols 
The Nitrodibenzofuran (NDBF) caging group, developed by Davies and coworkers, 
has also been used for alcohol and carboxyl protection. The NDBF scaffold 
contains an o-nitro moiety, which can be likened to the previously described ONB-
based caging groups. NDBF possesses the attractive features of ONBs, fast 
uncaging rate, large molar absorptivity, high quantum yields and high two-photon 
sensitivity. These improved properties demonstrated with alcohol and carboxyl 
protection highlight NDBF as an attractive candidate for variety of additional caging 
applications including thiol protection.  
In an effort to develop one- and two-photon activatable cysteine containing 
peptides, Distefano and coworkers for the first time applied NDBF for thiol 
protection.16 They have synthesized Fmoc-Cys(NDBF)OH and incorporated it into 
various peptides of interest through traditional Fmoc-based solid-phase peptide 
synthesis (SPPS). Since thiol protection was through stable thioether bonds, there 
was no evidence of protecting group migration or removal during SPPS, which is 
often observed when using thiocarbamate-protected cysteines. Using this 
strategy, they have developed a cysteine-protected version of the K-Ras derived 
peptide substrate for PFTase (60, Figure 1-20). Incubation of the caged peptide 
with PFTase resulted in no peptide recognition by the enzyme. However, 
irradiation at either 365 nm (one-photon) or 800 nm (two-photon) resulted in free 
peptide release, which was subsequently recognized by PFTase and became 
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farnesylated. HPLC analysis of the photolyzed samples over the course of 
irradiation time revealed one-photon uncaging quantum yield to be 0.2 at 365 nm 
and two-photon action-cross section to be 0.13 GM at 800 nm. Clean and 
quantitative conversion of the caged to the free peptide without any undesired 
byproduct formation was also confirmed. These data recommend NDBF as the 
most efficient thiol-protecting group explored to date.  
 
Figure 1-20 Photo-uncaging of KKKSKTKC(NDBF)VIM and subsequent 
farnesylation by PFTase enzyme. The figure was adapted from Mahmoodi et. al. 
[16] and reproduced. 
 
In order to show the utility of this approach for peptide activation inside cells, they 
utilized this strategy for caging peptides such as Hex-CLC(Sfarnesyl)-OMe (Figure 
1-21), which is a substrate for protein palmitoyl acyltransferase (PAT).  Prior to 
palmitoylation of Hex-CLC(Sfarnesyl)-OMe, the peptide resides mainly in the 
cytosol and the Golgi; however, palmitoylation of the free cysteine by PAT inside 
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cells results in migration of the peptide to the plasma membrane. Therefore, a thiol-
caged analogue of Hex-CLC(Sfarnesyl)-OMe cannot be a substrate for PAT and 
would thus localize in the cytosol/Golgi. Irradiation should uncage the peptide, 
revealing a free thiol which would become palmitoylated and result in peptide 
localization in the plasma membrane. 
 
Figure 1-21 Schematic Representation of NBD-HexC(NDBF)LC-OMe uncaging 
and subsequent palmitoylation. The figure was adapted from Mahmoodi et. al. 
[16] and reproduced. 
 
To test this hypothesis, a cysteine protected cell-penetrating peptide was 
developed and incubated with human ovarion carcinoma cells (SKOV-3). As 
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depicted in Figure 1-22, before any irradiation the peptide mainly localizes into 
cytosol; however, after irradiation the generated free peptide become 
palmitoylated and migrates to the plasma membrane. These results suggest that 
NDBF is an efficient thiol caging group for development of photo-activatable 
probes in cells and tissues useful for cell biology studies.  
a
 
Figure 1-22 Live-cell experiments showing temporal control of enzymatic 
palmitoylation via NDBF-thiol caging. (A) Images obtained by fluorescence 
confocal microscopy illustrating intracellular localization of fluorescently labeled 
peptide 20 in SKOV3 cells, before (top) and after (bottom) UV exposure. (B) 
Quantification of colocalization of peptide and membrane dye via Pearson’s 
coefficient analysis, indicating a significant increase in plasma membrane 
localization of peptide upon irradiation. The figure was adapted from Mahmoodi et. 
al. [16] and reproduced. 
 
1.5 p-Hydroxyphenacyl Cages for Thiols 
p-Hydroxyphenacyl (pHP) chromophores were introduced over a decade ago and 
have found a variety of applications as photo-removable protecting groups in 
enzyme catalysis, neurobiology and organic synthesis.4 Among the advantageous 
properties of pHP groups are water solubility, ease of synthesis and high yield of 
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installment. Pei and coworkers reported the first usage of pHP for thiol caging in 
enzymes (Figure 1-23).38 In their study, pHP was among various phenacyl 
derivatives that were used for generation of caged cysteine residues in tyrosine 
phosphatases. Direct treatment of the protein with pHP-Br (66a, Figure 1-23 A) 
resulted in selective modification of desired cysteine with high yield, confirmed by 
MS analysis. In order to evaluate the uncaging ability of the pHP compounds, 
caged enzymes were irradiated, and the restored activity was measured. 
According to enzymatic assays, photolysis at 350 nm restored 80% of the activity 
of the full enzyme (SHP-1), while only restored 30 % of the catalytic domain (SHP-
1(ΔSH2)). No further photochemical analysis was carried out in this research.  
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Figure 1-23 A) Mechanism of tyrosine phosphatase catalysis, and inactivation via 
pHP protection, B) In vivo enzymatic assays, showing restoration of tyrosine 
phosphatase activity upon UV irradiation which leads to pHP uncaging. The figure 
was adapted from Mahmoodi et. al. [38] and reproduced. 
 
Specht et. al. carried out a more in-depth analysis of pHP properties for thiol 
caging.39 They have utilized pHP for thiol protection in cysteine, thymidine 
nucleoside and glutathione derivatives (Figure 1-24 A). The caged biomolecules 
were synthesized with high yield due to the ease of installment of pHP as an α-
bromo acetophenone. Caged molecules were photolyzed at 312 nm and analyzed 
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by HPLC, UV-vis spectroscopy and MS. As shown in Figure 1-24 B, photolysis of 
compound 69a and 69b resulted in generation of unmasked thiol together with 
small fraction of disulfide with overall yield of 65 and 70%, respectively. Besides 
formation of the free thiols, three other photolysis side-products were generated in 
all three reactions: the expected p-hydroxyphenylacetic acid together with p-
hydroxy acetophenone as well as a new compound, the p-hydroxyphenylacetic 
thioester, derived from the biomolecules. Thioesters were produced in 30% yield, 
lowering the efficiency of thiol release. Uncaging quantum yield of 69b was 
measured to be 0.08 which is lower than the valued obtained for caged 
carboxylates and phosphates.  
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Figure 1-24 A) Thiol derivatives caged by pHP group. B) Product yields 
generated by 312 nm irradiation of pHP caged thiols. The figure was adapted 
from Mahmoodi et. al. [39] and reproduced. 
1.6 Benzoin and Benzoyl Cages for Thiols 
Benzoin- and Benzoyl-based groups have generally been utilized for carboxyl and 
alcohol protection. Application of these molecules for thiol caging is limited, with 
few reports in the literature. Hence, much needs to be explored regarding the 
efficiency and photo-physical properties of these chromophores for thiol protection. 
Bradley and Pirrung, utilized dimethoxy benzoin (DMB) for protection of benzyl 
thiol as a thiocarbonate.40 Photolysis at 350 nm in benzene resulted in high yield 
(> 95%) of conversion to the free thiol. No additional experiments were carried out 
in this article to further establish the photo-physical properties of this chromophore.  
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Porter and coworkers utilized 2-benzoylbenzoic acid for masking organic thiols as 
thioesters.41 To obtain efficient uncaging using this chromophore, photolysis 
reactions needed to be carried out in presence of proton donors (alcohols) or 
electron donors (amines) which imposes limitations on the utility of this caging 
group for biological applications.  According to NMR analysis, photolysis of caged 
thiols in the presence of cyclohexyl amine resulted in conversion to the free thiol 
(60%) and the corresponding disulfide (20%). No further photophysical 
measurements were performed on these caged thiols.  
 
Figure 1-25 Structures of 3,5-dimethoxybenzoin (DMB) caged phenylmethylthiol 
and 2-benzoylbenzoic acid caged aliphatic thiol. The figures were adapted from 
[40] and [41]. 
 
1.7 Conclusion 
Thiols play unique and important roles in various aspects of biology and chemistry 
and have strong potential for use in biomaterial applications. This is in part the 
result of their high reactivity and nucleophilicity. On the other hand, sulfhydryl is a 
relatively poor leaving group in comparison to carboxyl and phosphate. These 
properties pose specific challenges when choosing efficient and broadly applicable 
caging groups suitable for thiol caging. Therefore, several caging groups have 
been explored and developed for sulfhydryl protection. Table 1-1 summarizes 
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spectral and photochemical properties of photocleavable protecting groups 
covered in this review.  
Thus far, ONB-based groups are the most commonly used approach for thiol 
protection. They are easy to install, possess modest quantum yield and high yield 
of photo-conversion. These compounds have been extensively used as orthogonal 
cysteine protecting group for peptide and protein synthesis as well as development 
of photoactivatable sulfhydryl-containing probes for biological studies. 
Unfortunately, ONBs generally have low one- and two-photon absorptivity, which 
limits their applicability in biological studies where photo-damage is a concern and 
uncaging in deeper tissues is necessary.  
Alternatively, coumarin-based protecting groups possess longer absorption 
maxima, larger one- and two-photon absorptivity. Their quantum yield is relatively 
low; however, and more importantly their release efficiency is largely limited by the 
formation of an unwanted photo-isomerized by-product. Recent development of 
mBhc, which does not undergo photo-isomerization upon irradiation, significantly 
extends the utility of coumarin-based compounds for thiol protection. Additionally, 
the systematic design of mBhc which was guided by mechanistic studies of the 
photo-triggered isomerization of Bhc caged-thiols, sets the stage for further 
development of more efficient caging groups based on coumarin structure. 
Recently, several research groups have developed coumarin derivatives, with 
substitution at their C-3 endocyclic position, similar to mBhc. These compounds 
have been successfully used for alcohol and carboxyl release. Hence, they will be 
great candidates to be tested for sulfhydryl protections, as well.42,43  
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Phenacyl has shown to be easily installed on small molecules as well as proteins, 
and possess modest quantum yield. However, their release efficiency is limited by 
a formation of an unwanted thioester-based by-product. Their absorptivity is also 
comparatively low and moreover they are not two-photon active. More work is 
needed to fully evaluate the efficiency and reliability of benzoin and benzoyl cages 
for thiols. Dimethoxy benzoin has only been used for masking thiol as a 
thiocarbonate, but never used for direct thiol protection. Benzoyl group showed 
high yield of photo-release, although photolysis was supposed to be carried out in 
presence of amines, which is not ideal for biological studies.  
To date, NDBF is the most promising photocleavable protecting group utilized for 
thiol caging. This compound possesses large absorptivity, high quantum yield, and 
large two-photon sensitivity, together with quantitative thiol photorelease. NDBF 
has been successfully utilized for sulfhydryl protection in both peptides and organic 
molecules and was shown to be cleaved via both one and two-photon irradiation. 
The only problematic feature of this protecting group is its comparatively low water 
solubility, particularly when used for caging poorly water soluble bio-agents. This 
necessitates development of more water soluble NDBF analogues. Additionally, 
the reliability of NDBF for thiol protection warrants further modification of this 
compound to generate even more efficient NDBF-based caging groups with longer 
λmax and significantly improved two-photon sensitivity. This also suggests ONB-
based groups with extended conjugation, such as ortho-nitrobiphenyl derivatives 
developed by Specht and coworkers,44 and 2-(4-nitrophenyl)benzofuran 
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developed by Kobayashi and coworkers,45 as great candidates to be evaluated for 
sulfhydryl protection.  
Caging Groups Spectral and Photo-
chemical properties  
Cons and Pros when 
used for thiol caging 
Ortho-nitrobenzyl 
(ONB) 
ɛ(M-1cm-1) = 2000 (7) - 
4000(9) 
λmax(nm) = 265 (7), 356 (9) 
Qu = 0.04 – 0.16 
 
- Modest uncaging yield. 
- Case sensitive uncaging yield.  
- Low one- and two- photon 
absorptivity 
Coumarin ɛ(M-1cm-1) = 11000 (42), 
14000 (44), 18500 (43) 
λmax (nm) = 324 (42), 365 
(43), 384 (44) 
Qu = 0.01 
δu (GM) = 0.16 GM (at 800 
nm)  
- Low uncaging yield: Mainly photo-
isomerizes upon uncaging except 
for mBhc-protected thiols. 
- Two-photon active. 
Nitrodibenzofuran 
(NDBF) 
ɛ(M-1cm-1) = 18400 
λmax = 330 nm 
Qu = 0.2 
δu (GM) = 0.13 GM (at 800 
nm)  
 
- Quantitative uncaging yield 
- High one- and two-photon 
sensitivity. 
p-Hydroxyphenacyl 
(pHP) 
ɛ(M-1cm-1) = 3000-12000 
(highly pH dependent) 
λmax = 278 - 340 nm 
Qu = 0.08 
- Modest uncaging yield: Formation 
of a thio-ether byproduct limits the 
yield. 
- Low one- and two-photon 
absorptivity. 
 
Table 1-1 Overview of spectral and photo-chemical properties of thiol caging 
groups reviewed in this article.  
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2 Nitrodibenzofuran: A One- and Two-Photon Sensitive 
Protecting Group That Is Superior to Brominated 
Hydroxycoumarin for Thiol Caging in Peptides 
 
2.1 Introduction 
The ability of light to traverse various chemical and biological barriers and be 
modulated by time and amplitude makes light- regulated molecules unique tools 
for a plethora of applications in the areas of chemistry and biology.1−4 
Photoremovable protecting groups, also known as caging groups, are one of the 
most important light-regulated tools, which can be utilized to mask specific 
functional groups in molecules such that they can be cleaved on demand upon 
irradiation.5,6 In biological applications, this typically involves masking a 
biomolecule with a caging group to produce a compound whose biological activity 
is either increased or decreased upon uncaging.7−9 The recent development of 
two-photon-sensitive protecting groups, which allow uncaging using near-infrared 
(near-IR) irradiation, has resulted in significant improvements in the spatiotemporal 
resolution of uncaging as well as increased penetration with lower 
phototoxicity;10−14 the latter attribute is of particular importance for the use of caged 
molecules in tissue samples or intact organisms that are essentially opaque to UV 
light. Due to inherent differences in the chemical reactivity of various functional 
groups, there is no single photocleavable protecting group that works efficiently for 
caging all functionalities. Hence, protecting group selection must be performed on 
a case by case basis.15,16 
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Thiol-containing compounds play vital roles in many aspects of biology (e.g., 
controlling cellular redox state),17 protein chemistry (e.g., protein and peptide 
folding, native chemical ligation18), and enzymology.19 Hence, significant efforts 
have gone into the preparation of proteins and ligands/substrates containing caged 
thiols that can be triggered with light to reveal bioactive species;20−24 for that 
purpose, several protecting groups have been explored.25−29 The most widely used 
approach for thiol protection involves caging with o-nitrobenzyl (ONB) groups. 
Among the advantages of ONB groups are high one-photon quantum efficiency 
and high yield of free compound produced upon photolysis.30 However, they are 
poor chromophores with low two-photon sensitivities which limit their biological 
applications. To address this issue, coumarin-based protecting groups have been 
recently employed, which absorb light at longer wavelengths and possess 
significantly higher one- and two-photon absorptivity.31 In one important study, 
Hagen and co-workers harnessed the chromatic orthogonality of ONB- and 
coumarin-based protecting groups to introduce a wavelength-selective thiol caging 
system.32 Using a combination of those protecting groups, they were able to 
selectively uncage different thiols in a peptide sequence using different 
wavelengths for UV irradiation; however, no two-photon photochemistry was 
explored. In another novel study, Shoichet and co-workers incorporated 
brominated hydroxycoumarin (Bhc)-protected thiols into hydrogels that allowed 
them to perform light- induced protein patterning within those materials with high 
spatial control.33,34 The high two-photon sensitivity of Bhc allowed them to create 
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3D protein patterns inside these polymeric scaffolds for tissue engineering 
applications. 
In recent work, we demonstrated that Bhc could also be used for thiol protection 
of a peptidomimetic enzyme inhibitor.35 The high one- and two-photon sensitivity 
of Bhc allowed efficient uncaging of the inhibitor inside cells for biological 
applications. Inspired by these results, we reasoned that Bhc could also be used 
for thiol protection of cysteine-containing peptides. In the work reported here, we 
first explored the use of Bhc-protected cysteine in peptides. While they are 
straightfor- ward to prepare using Fmoc-Cys(Bhc)-OH as a building block in solid-
phase peptide synthesis (SPPS), irradiation of such caged peptides was 
complicated by the generation of an unwanted photoisomer instead of the free 
thiol. Using NMR analysis,we wereableto confirm the structure of the photoisomer 
to be a 4-methylcoumarin-3-yl thioether, in agreement with a previous prediction 
by Hagen and co- workers.32 Further analysis of several different peptide 
sequences revealed that the photocleavage efficiency of Bhc- protected thiols is 
context dependent and typically leads to formation of a photoisomer as the major 
product. To circumvent this problem, we next explored using nitro- dibenzofuran 
(NDBF)36 as a thiol caging group since it manifests a two-photon cross-section 
comparable to that of Bhc. Thus, cysteine-containing peptides were prepared 
where the thiol was protected with an NDBF group. This was accomplished by 
preparing Fmoc-Cys(NDBF)-OH and incorporating it into peptides via standard 
SPPS. In contrast to that of Bhc-caged thiols, irradiation of NDBF-protected thiols 
at 365 nm resulted in clean conversion to the free mercaptan. Deprotection was 
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also obtained via irradiation at 800 nm, where the two-photon action cross-section 
was measured to be comparable to that of Bhc-protected acetate (Bhc-OAc). To 
probe the utility of this protecting group for biological experiments, thiol group 
uncaging was carried out using a K- Ras-derived peptide containing an NDBF-
protected cysteine. Irradiation of that molecule in the presence of protein 
farnesyltransferase (PFTase) and farnesyl diphosphate (FPP) resulted in the 
formation of the free thiol form and subsequent enzymatic conversion to a 
prenylated species. Those experi- ments indicate that one- and two-photon 
deprotection can be performed under mild conditions that allow enzymatic activity 
to be retained. In order to illustrate the utility of this strategy for the development 
of caged peptides that can be activated via irradiation inside live cells, the thiol of 
a cell-penetrating peptide known to be a substrate for palmitoyl acyltransferase 
was protected as a NDBF thioether. Irradiation of human ovarian carcinoma 
(SKOV3) cells, preincubated with the probe, resulted in migration of the peptide 
from the cytosol/Golgi to the plasma membrane (visualized via confocal 
microscopy) due to enzymatic palmitoylation. These data suggest that the NDBF 
group should be useful for caging thiols in peptides and potentially larger proteins 
assembled via native chemical ligation18 for biological applications. The high 
uncaging yield of NDBF-caged thiols upon one- and two-photon irradiation, 
together with the facile incorporation of caged cysteine via standard SPPS into 
peptides containing multiple cysteines, make this a highly versatile strategy for 
studying cysteine- containing peptides and proteins. 
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2.2 Results and Discussion 
 
2.2.1 Synthesis and Studies of the Photolysis of Bhc- Protected 
Cysteine-Containing Peptides.  
 
2.2.1.1 Synthesis of Bhc-Protected Fmoc-Cysteine and 
Incorporation into Peptides.  
 
Previous studies in our laboratory have shown that Bhc can be used for photolabile 
thiol protection of a peptidomi- metic enzyme inhibitor. The caged molecule 
manifested efficient cleavage to yield a free thiol upon one- and two- photon 
irradiation, allowing it to be used for biological applications in cell culture. 
Therefore, in order to develop photolabile S-protected cysteine-containing 
peptides, we initially used Bhc as a caging group. Our strategy was to prepare 
Bhc-protected Fmoc-cysteine and incorporate that into a peptide of interest 
through SPPS; the synthesis of a form of cysteine suitable for SPPS is depicted in 
Scheme 2-1. The phenolic hydroxyl group of Bhc-chloride (1) was protected using 
chloromethyl methyl ether and triethylamine to give MOM-protected Bhc-Cl (2) in 
89% yield. This chloride was subsequently used to alkylate Fmoc-cysteine methyl 
ester under mild acidic conditions, using Zn(OAc)2 as a catalyst,38 to produce 3 in 
80% yield. Saponification of the methyl ester using trimethyl tin hydroxide39 under 
reflux generated the desired caged Fmoc-cysteine derivative (4) in 81% yield. 
The general route for synthesis of caged peptides employed standard SPPS 
conditions, in which Fmoc-protected residues were added sequentially to a peptide 
anchored on Wang resin. 
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Scheme 2-1 Synthesis of Bhc-Protected Fmoc-Cys and Incorporation into a 
Peptide via SPPS. 
 
The only exception involved the incorporation of the caged Fmoc-Cys residue, 
where the coupling time was increased to 6 h to ensure quantitative incorporation 
of the nonstandard residue. Final treatment of the resin-bound peptide with acid 
(standard conditions using Reagent K) removed all side-chain protecting groups, 
including the MOM group present on the Bhc moiety, and cleaved the polypeptide 
from the resin to generate the desired caged molecule. This strategy was 
successfully employed to synthesize a caged form of K-Ras peptide, 5, that 
includes an N-terminal fluorescein group. While the uncaged form of that peptide 
is a known substrate for the enzyme, PFTase, the Bhc-protected form is not. The 
goal was to use light to uncage the peptide and restore its ability to be recognized 
by the enzyme and undergo farnesylation. 
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2.2.1.2 Photolysis of Bhc-Protected Cysteine-Containing 
Peptides.  
 
Once the fluorescein-labeled caged peptide was successfully synthesized and 
purified, the next step was to verify its uncaging efficiency upon photolysis. Hence, 
solutions of caged peptide in photolysis buffer (1 mM DTT in 50 mM PB at pH 7.2) 
were irradiated using 365 nm light in a Rayonet photoreactor for varying amounts 
of time (Figure 2-1A). Each sample was analyzed by RP-HPLC and monitored by 
fluorescence. Inspection of the HPLC traces (Figure S1) revealed that the starting 
peptide peak disappeared over time, with concomitant formation of a new peak 
with a later retention time. Surprisingly, further analysis of the reaction mixture via 
ESI-MS revealed that the photolytic product and non-irradiated starting peptide 
had identical masses, indicating that irradiation causes isomerization instead of 
uncaging. 
Extracted ion current (EIC) chromatograms obtained by LC- MS analysis (Figure 
2-1B,C) clearly revealed the disappearance of the starting peptide (tR = 8.45 min, 
m/z = 635.26) upon photolysis and concomitant formation of a new peak with 
identical mass (tR = 8.70 min, m/z = 635.26) that corresponds to the 
photoisomerized product. To study whether any free (uncaged) peptide 6 was 
produced upon irradiation, 6 was synthesized by an independent route and 
subjected to LC-MS. Analysis of the LC-MS traces of the irradiated peptide showed 
no evidence for the presence of free peptide ions that match with the authentic 
standard (Figure 2-1C, D). 
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Figure 2-1 (A) Uncaging reaction of Bhc-protected cysteine-containing peptide 5 
upon UV irradiation. LC-MS analysis of photolysis of peptide 5: (B) EIC 
chromatogram (m/z = 635.20−635.30) of a sample of 5 in photolysis buffer, (C) 
EIC chromatogram (m/z = 635.20−635.30) of sample of 5 after 120 s photolysis 
showing the formation of a photoisomer, and (D) EIC chromatogram (m/z = 
551.20−551.30) of a standard sample of free peptide 6b showing that no uncaged 
product was detected upon photolysis of 5. 
 
We initially hypothesized that the observed isomerization might be due to 
photoinduced migration of the Bhc group to a side-chain amine group of a 
neighboring lysine residue. This hypothesis was tested by MS/MS fragmentation 
analysis, since migration of Bhc to other residues would change the fragmentation 
of the photoisomer relative to the starting peptide. Interestingly, MS/MS analysis 
revealed that the two isomers have the same backbone fragmentation pattern 
(Table S1). Of particular importance, two of the main fragments present in both the 
photoisomer and the caged peptide are the doubly charged X4 and B7 ions (Figure 
S2), which clearly indicate that the Bhc group remains connected to cysteine even 
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after irradiation. This observation is not consistent with the hypothesis of 
phototriggered Bhc migration to lysine residues and indicates that a rearrangement 
occurs directly on the caged cysteine residue. 
The high extent of photoisomerization observed upon photolysis of compound 5 
was somewhat contrary to our previous results with Bhc-protected inhibitors, 
where photolysis led to efficient (>85%) uncaging. Thus, we considered the 
possibility that the photocleavage of Bhc-caged thiols may be context dependent. 
To test this hypothesis, two additional peptides were synthesized in which the 
location of caged cysteine was moved by one residue along the peptide sequence. 
Each peptide was photolyzed separately, and the resulting products were analyzed 
by LC-MS. Based on the EIC data (Figures S3 and S4), photolysis of 
KKKSKTCC(Bhc)IM produced only the photoisomer and no detectable uncaged 
peptide. In contrast, photolysis of KKKSKTC(Bhc)CVIM generated a mixture of 
both the photoisomer and free peptide. This hypothesis was also tested with 
shorter peptides where C(Bhc)VLS showed formation both uncaged and 
isomerized product (Figure S5), whereas photolysis of dansyl-GC(Bhc)VLS did not 
produce any uncaged peptide (Figure S6). These data confirm that the efficiency 
of Bhc photocleavage is highly dependent on its surrounding chemical 
environment. It is worth noting that photoisomerization was also observed upon 
two photon excitation of C(Bhc)VLS (Figure S7). 
Previously reported mechanistic studies have demonstrated that the 
photocleavage of coumarin-based protected carboxylic acids results in scission of 
the C−O bond to produce a reactive carbocation which is rapidly quenched by 
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water when the latter is used as the solvent.40 However, an alternative pathway 
could involve reaction of the cationic intermediate with an internal nucleophile via 
an intramolecular process; such a mechanism would give rise to an isomeric 
product consistent with the observations reported here. To examine this possibility, 
photolysis reactions were performed in the presence of high concentrations of 
thiols in order to increase the rate of trapping. Thus, aqueous solutions of 5 were 
irradiated in the presence of excess DTT (up to 200 mM), and analyzed by RP- 
HPLC. Interestingly, none of those experiments revealed any measurable change 
in the extent of photoisomerization. These results suggest that the photo-
rearrangement may proceed through a concerted intramolecular mechanism; 
however, additional experiments are needed to thoroughly address this question. 
2.2.1.3 NMR Analysis of Bhc Photo-rearrangement.  
 
The possibility of photo-rearrangement of related amino-coumarin- protected 
cysteines has been previously suggested by Hagen and co-workers; however, in 
their publication, no analysis was performed to conclusively identify the structure 
of photoisomer generated.32 Therefore, after first observing the photo- 
rearrangement of Bhc-caged thiols by mass-spectroscopy, we decided to 
determine the structure of the isomeric product using NMR methods. In order to 
obtain sufficient material for NMR analysis, a solution of caged peptide 5 was 
irradiated and the photoisomer was isolated via preparative RP-HPLC purification. 
1H NMR spectra were obtained using a sensitive cryoprobe instrument. As shown 
in Figure S8A,B for 5 and the photoisomer, respectively, both compounds have 
very similar spectra, with the exception of a distinctive peak at 6.2 ppm present in 
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the spectrum of 5 that is missing in the spectrum of the photoisomer; 
concomitantly, a new signal appears at 2.4 ppm in the spectrum of the isomer that 
is not present in the spectrum of 5. Comparison of those spectra with the Bhc 1H 
NMR spectrum31 indicates that the signal at 6.2 ppm corresponds to the aryl proton 
at the 3 position of Bhc (Scheme 2-2). The disappearance of that peak and the 
appearance of the new signal at 2.4 ppm are consistent with a photoinduced 1,3 
shift of the sulfur atom from the exocylic position to the 3 position to give 
intermediate 9 followed by tautomerization to yield a 4-
methylbromohydroxycoumarin-3- yl thioether (10) as previously suggested by 
Hagen and co- workers.32 In such a case, the resonance at 2.4 ppm could be 
attributed to the presence a methyl group in the final photoproduct 10. 
 
Scheme 2-2 Hypothesized Mechanism of Photoisomerization of Bhc-Caged 
Cysteine. 
 
Due to the complicated 1H NMR spectra of the peptides, we decided to validate 
the proposed hypothesis using a simpler model system. Hence, Bhc-protected 
cysteamine (11, Figure 2-2), which has a simple structure and a straightforward 
synthetic route, was chosen as the model system. Additionally, this specific 
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molecule has been previously used by Shoichet and co- workers for phototriggered 
uncaging of thiol functionality inside hydrogels.28 Therefore, knowing all the 
complexities due to context dependence of Bhc photocleavage, we were also 
interested to see how efficient this compound could undergo uncaging. 
Compound 11 was synthesized following a previously reported procedure.33 
Solutions of 11 were irradiated using 365 nm light in a Rayonet photoreactor for 
varying amounts of time followed by analysis via RP-HPLC with UV detection. That 
allowed the disappearance of 11 as well as the formation of the isomeric 
rearrangement product 12 and Bhc-OH (7) (formed from the desired uncaging 
reaction) to be monitored. Inspection of the HPLC data (Figure S9) indicates that 
the major product of photolysis of compound 11 under these conditions is the 
photoisomer 12, the product with a higher retention time) with a smaller amount of 
the desired uncaged product formed, as indicated by the low intensity peak 
corresponding to 7. 
Compound 11 was synthesized following a previously reported procedure.33 
Solutions of 11 were irradiated using 365 nm light in a Rayonet photoreactor for 
varying amounts of time followed by analysis via RP-HPLC with UV detection. That 
allowed the disappearance of 11 as well as the formation of the isomeric 
rearrangement product 12 and Bhc-OH (7) (formed from the desired uncaging 
reaction) to be monitored. Inspection of the HPLC data (Figure S9) indicates that 
the major product of photolysis of compound 11 under these conditions is the 
photoisomer 12, the product with a higher retention time) with a smaller amount of 
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the desired uncaged product formed, as indicated by the low intensity peak 
corresponding to 7. 
Reactions containing Bhc-cysteamine (11) and its corre- sponding photoisomer 12 
were separated by RP-HPLC and the purified compounds analyzed by NMR 
spectroscopy. Compar- ison of the 1H NMR spectrum of 11 with that of compound 
12 revealed characteristic changes in the proton signals corre- sponding to those 
observed in the peptide experiment (Figure 2-2). Methylene (Hd) and aryl (He) 
protons present in the starting material are absent in the spectrum of the 
photoisomer. In addition, a new signal at 2.72 ppm (Hh) corresponds to the new 
methyl group that is generated. Also of note, the triplet signal (H′b), corresponding 
to the methylene protons of cysteamine, shifts downfield relative to that of the 
starting compound (Hb) as a result of thiol conjugation with double bonds which 
renders the thiol a stronger electron-withdrawing group; alternatively, this shift may 
be due to a ring current effect. These observations convincingly support the 
suggested mechanism for photo-rearrangement and the proposed structure of the 
photoisomer. A similar photolysis experiment was performed in D2O. LC-MS 
analysis clearly indicates formation of a mono deuterated photoisomer (Figure 
S10). This data demonstrates that there is a solvent-derived proton incorporated 
in the product, consistent with the mechanism proposed for photo-rearrangement 
described in Scheme 2-2. 
To obtain an accurate ratio of the extent of uncaging versus photo-rearrangement, 
a sample of compound 11 that had been subjected to irradiation, and thus 
contained both uncaged and photoisomerized product, was analyzed by 1H NMR 
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spectros- copy (Figure S11). Using integration values obtained from characteristic 
protons from each product, a ratio for uncaging versus photoisomerization of 1:10 
was calculated. Thus, while Shoichet and co-workers have used 11 (under 
different conditions) to successfully uncage a thiol upon photolysis, the 
experiments reported here revealed that the major product of this reaction is an 
unwanted photoisomer. Overall, the variability obtained using Bhc suggests that it 
is not generally applicable as a caging group for thiols and that there is a real need 
for an alternative caging group for general usage. 
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Figure 2-2 (A) Photolysis of Bhc-protected Boc-cysteamine and the resulting 
photolytic products. (B) 1H NMR spectrum of Bhc-protected Boc-cysteamine 
(top) and the corresponding photoisomer (bottom). 
 
2.2.2 Use of Nitrodibenzofuran for Development of Caged 
Cysteine-Containing Peptides.  
2.2.2.1 Alternative Strategy Using NDBF.  
 
The initial goal of our work was to identify a protecting group that could be used to 
cage the thiol group of cysteine when present within a peptide that would be 
efficiently deprotected through UV irradiation as well as near- IR light via a two-
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photon process. Although Bhc has shown reasonable one- and two-photon 
uncaging efficiencies for protection of various functionalities including 
carboxylates, phosphates and carbamates, the experiments described above 
revealed its photocleavage efficiency is unpredictable when used with thiols; 
moreover, the main product formed upon irradiation is often an unwanted 
rearrangement byproduct in lieu of the desired free thiol. To address these 
limitations, we elected to examine another type of caging group that undergoes 
uncaging via a process significantly different from coumarin- based compounds. 
o-Nitrobenzyl (ONB)-based caging groups have been extensively used for thiol 
photocaging. Despite, their relatively slower uncaging rate (compared with 
coumarins), they undergo photolysis with minimal byproduct formation. However, 
ONB- based compounds suffer from low one-photon and especially low two-
photon absorptivity which limits their applications in cellular media and live tissue. 
In 2006, Momotake et al. introduced NDBF, a more extensively conjugated form 
of ONB, as a new caging group with high one- and two-photon sensitivity.36 This 
compound has previously been used for protection of hydroxyl functionalities and 
showed rapid and efficient uncaging upon one- and two-photon irradiation.41 Due 
to its advantages over traditional ONB-based molecules, we decided to explore its 
applicability for photocaging of thiols in order to prepare peptides containing caged 
cysteine residues. 
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2.2.2.2 Synthesis of NDBF-Protected Fmoc-Cys-OH and 
Incorporation via SPPS.  
 
Similar to the synthesis of Bhc- caged peptides, the strategy pursued here was to 
first synthesize Fmoc-cysteine containing an NDBF-protected thiol [Fmoc- 
Cys(NDBF)-OH] and then incorporate that into a peptide through standard SPPS. 
Starting from dibenzofuran, NDBF-Br (13) was synthesized in four steps (Scheme 
S1). Next, as described in Scheme 2-3, Fmoc-cysteine methyl ester was first 
reacted with NDBF-Br under acidic conditions, to produce compound 15 in 70% 
yield. The resulting methyl ester was then hydrolyzed using (CH3)3SnOH to yield 
Fmoc-Cys(NDBF)-OH (16) in 75% yield. 
The resulting protected cysteine residue was successfully incorporated into 
several K-Ras-derived peptides (17a,b) via standard SPPS as described for the 
related Bhc-protected peptides noted above; the final products were characterized 
by ESI-MS-MS to confirm the presence of the NDBF group after the global 
deprotection step (Table S2). Since NBDF protection of cysteine involves a 
thioether bond, there was no evidence of any S-to-N shift or deprotection occurring 
during synthesis, a problem that does occur when thiocarba- mate-based 
protection strategies are used.32 
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Scheme 2-3 Synthesis of NDBF-Protected Fmoc-Cys-OH and Incorporation into 
Peptide Sequence via SPPS. 
 
 
Scheme 2-4 Light-Triggered Uncaging of NDBF-Protected K- Ras Peptide (17b). 
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2.2.2.3 One- and Two-Photon Photolysis of NDBF-Caged 
Cysteine Peptides.  
 
After completion of the synthesis of the fluorescently labeled caged peptide 17b, 
photolysis experiments were conducted to probe for the formation of the uncaged 
peptide containing a free thiol upon photolysis (Scheme 2-4). In this experiment, a 
solution of 17b was irradiated at 365 nm for 45 s and subjected to RP-HPLC. As 
can be seen from the chromatograms shown in Figure S12, photolysis resulted in 
the disappearance of the peak corresponding to the starting peptide 17b and 
concomitant appearance of a new peak tentatively assigned as 6b. ESI-MS/MS 
analysis confirmed that the newly formed peak corresponds to the expected free 
peptide (Figure S12, Table S3). The absence of any unwanted photoproducts 
based on an HPLC trace devoid of any other significant products, suggests that 
that photolysis of NDBF-caged peptides undergo conversion to free peptide upon 
UV irradiation with high efficiency. In order to further evaluate the general 
applicability of this strategy, a second peptide, dansyl-GC(NDBF)VLS was also 
synthesized and studied. Analysis of a photolysis reaction containing that peptide 
showed complete conversion to the free peptide upon irradiation (Figure S13), 
unlike its Bhc-protected counterpart (compare with Figure S6). These data suggest 
that NDBF lacks the limitations and undesired reactivity manifested by Bhc for thiol 
caging. 
One-photon uncaging kinetics of compound 17b were evaluated by irradiating 
solutions of 17b for varying periods of time followed by analysis via RP-HPLC 
(Figure 2-3A). Based on those data, the uncaging quantum yield (εΦ) of peptide 
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17b was measured to be 0.2. The quantum yield measured in this experiment is 
somewhat lower than the value reported for NDBF used for caging hydroxyl 
functionality (0.7),36 which may be due to the light absorption of fluorescein 
attached to the peptide. However, due to the high molar absorptivity of NDBF, 
which results in a high εΦ value, the uncaging t1/2 was quite short (25 s) under the 
photolysis conditions (standard Rayonet reactor). 
 
Figure 2-3 (A) HPLC quantification of disappearance of the starting peptide 
(17b) and formation of the uncaged peptide (6b) as a function of irradiation time 
at 365 nm. (B) HPLC quantification of uncaging of 17a as a function of two-
photon irradiation time (800 nm, pulsed Ti:Saphire laser, 210 mw, 80 fs pulse 
width). Photolysis reactions were performed in 200 and 300 μMsolutions of 17b 
and 17a respectively, containing 1 mM DTT in 50 mM PB, pH 7.5. 
 
Since the NDBF-caged peptide showed useful uncaging properties upon one-
photon irradiation, further experiments were performed to evaluate its two-photon 
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uncaging efficiency. Thus, solutions of 17a were irradiated at 800 nm using a 
Ti:Saphire laser and the photolysis products were again analyzed by RP-HPLC 
and confirmed by LC-MS (Figure S14). The two-photon action cross-section of 17a 
was measured using 6-bromo-7-hydroxycoumarin-4-ylmethyl acetate (Bhc-OAc) 
as a reference.31 Even though the extinction coefficient of the NDBF chromophore 
at 400 nm is less than 10% of that at λmax (325 nm), a value of 0.13 GM for 17a 
uncaging at 800 nm was calculated (Figure 2-3B). It should be noted that this value 
would be greater if the two-photon irradiation was performed at lower wavelengths 
where the extinction coefficient is closer to the maximum value although tissue 
penetration would be less. Overall, these results demonstrate that NDBF is an 
efficient thiol caging group that undergoes clean photocleavage to generate a free 
thiol upon one- or two-photon irradiation. 
2.2.2.4 One- and Two-Photon-Triggered in Vitro 
Farnesylation of a Caged K-Ras Peptide.  
 
Since the NDBF-caged peptide demonstrated good uncaging efficiency, we next 
sought to examine its utility in a more biologically relevant context. Protein 
prenylation is a critical process that affects key signaling mechanisms within cells 
involved in a plethora of functions from growth to differentiation.42 Prenyl groups 
are appended to proteins via thioether linkages formed by alkylation of specific 
cysteine residues catalyzed by prenyltransferases including PFTase, which 
transfers a farnesyl (C15) group.43 Thus, a K- Ras-derived peptide incorporating a 
caged cysteine residue at the site of prenylation should not be a substrate for 
PFTase; however, upon irradiation, the resulting peptide manifesting a free thiol 
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produced by photocleavage of the protecting group should be an efficient substrate 
and become farnesylated (Figure 2-4A). In order to test this, a series of 
experiments was conducted in which a caged peptide was treated with FPP in 
prenylation buffer (15 mM DTT, 10 mM MgCl2,50 μM ZnCl2, 20 mM KCl), with or 
without enzyme addition and UV light exposure. 
As predicted, the caged peptide 17b was not farnesylated when treated with yeast 
PFTase. LC-MS analysis of reaction mixture indicates only the presence of the 
caged peptide (m/z = 630.87, Figure 2-4A). Photolysis of 17b for 60 s at 365 nm, 
in the absence of enzyme, generated the uncaged peptide, as confirmed by the 
formation of a new peak with the expected m/ z value (m/z = 551.21, Figure S15). 
However, photolysis of 17b in the presence of PFTase led to the generation of a 
farnesylated peptide (19b). The new peak with the retention time of 10.55 min has 
a mass to charge ratio of 619.26 which is in good agreement with the calculated 
value (C92H145N16O20S23+, 619.34) for the farnesylated peptide. This observation 
clearly illustrates that the peptide undergoes UV-dependent farnesylation which 
could make it a useful probe for studying prenylation reactions in a 
spatiotemporally controllable manner. 
Since, it would be useful to employ such caged peptides for studies in tissue or 
whole organisms where UV light cannot efficiently penetrate, the ability of 17a to 
undergo farnesylation by irradiation at longer wavelengths via two-photon 
excitation was examined. Accordingly, in vitro farnesylation reactions, similar to 
those described above for UV irradiation, were conducted using an 800 nm laser 
light source. As was noted before, treatment of the caged peptide with enzyme in 
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the presence of FPP without irradiation did not alter the starting peptide (Figure 2-
4). Irradiation of 17a (m/z = 511.62) at 800 nm for 2.5 min in the absence of 
enzyme, generated the free peptide 6a, as confirmed from the EIC chromatogram 
(m/z = 431.95, Figure 2-4C). Treatment of 17a with the enzyme along with 2.5 min 
two-photon irradiation generated the farnesylated peptide 19a, as shown by the 
appearance of an ion of m/z = 499.99 (Figure 2-4D). In summary, these data 
demonstrate that an NDBF-caged K-Ras peptide (17a) is capable of undergoing 
farnesylation triggered by 800 nm light via two-photon excitation (also see Figure 
S16). 
2.2.3 Light Activation of a Caged Peptide inside Live Cells.  
 
One of the important goals for photocaging of bioactive molecules, including 
peptides, is to modulate their activity by irradiation inside cells in order to study 
biological processes. Since farnesylation of NDBF-caged K-Ras peptide was 
efficiently and rapidly triggered by UV and IR irradiation in vitro, we decided to 
explore the same strategy to develop peptides that can be efficiently activated 
upon irradiation inside live cells. 
Protein palmitoylation is a post-translational modification that plays critical roles in 
subcellular protein localization. In this process, palmitoyl acyltransferases (PATs) 
covalently attach a C16 palmitate group via thioesterification to one or more 
specific cysteine residues present in protein targets.44 This modification causes 
proteins to be more hydrophobic and migrate to the plasma membrane where they 
are active;45 prenylated proteins including H-Ras and N-Ras are commonly 
58 
 
palmitoylated. Draper et al. have developed several fluo- rescently labeled cell-
penetrating peptides including NBD-Hex-CLC(S-farnesyl)-OMe (21, Scheme 2-5), 
which they have used to study palmitoylation inside cells.46 When the free cysteine 
in the peptide is not modified, it localizes mainly in the cytosol and the Golgi; 
however, palmitoylation of the free cysteine by PATs inside cells results in the 
migration of the peptide to the plasma membrane. Therefore, a caged version of 
Hex-CLC(S-farnesyl)-OMe (20), cannot be a substrate for PAT and would thus 
localize in the cytosol/Golgi; however, irradiation should uncage the peptide, 
revealing a free thiol that would become palmitoylated and hence gradually migrate 
to plasma membrane. While peptide 21 has previously been shown to traffic to the 
plasma membrane, it was impossible to temporally control that process since 
cellular uptake and trafficking could not be uncoupled. However, the availability of 
a caged form makes this possible. 
Peptide 20 was prepared using a cysteine anchoring method developed by our 
group for the synthesis of C-terminal methyl esters (Figure S17).47 Trityl chloride 
resin was first treated with Fmoc-Cys-OMe and DIEA in CH2Cl2 overnight to afford 
Fmoc-cysteine-loaded resin. The peptide was extended on the resin through 
standard SPPS employing Fmoc-based chemistry. Reagent K treatment cleaved 
the peptide from the resin which was then farnesylated via treatment with farnesyl 
bromide and Zn(OAc)2 under acidic conditions. 
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The final caged peptide was purified by preparative RP-HPLC. Despite the 
presence of two cysteines in the sequence, there was no evidence of NDBF 
scrambling between the two thiols during the synthesis, consistent with the stability 
afforded by the NDBF thioether linkage. Those results are in contrast to those 
obtained when thiocarbonate strategies are used for thiol protection in peptides 
containing multiple cysteines where migration via acyl transfer readily occurs. 
Moreover, studies have shown that carbonates and thiocarbonates are prone to 
hydrolysis via esterases, thus limiting their applicability in living systems.48 In 
general, the efficient assembly of caged peptide 20 highlights the utility of NDBF-
protected cysteine and how it can be employed for the synthesis of a variety of 
Figure 2-4 (A) Photo-uncaging of 17 and its subsequent farnesylation by 
enzyme. (B) EIC chromatogram (m/z = 511.62) of a 7.5 μM solution of 17a in 
prenylation buffer containing PFTase without irradiation. (C) EIC chromatogram 
(m/z = 431.95) of a solution of 17a after 2.5 min irradiation at 800 nm (Ti:sapphire 
laser, 170 mW, 90 fs) in prenylation buffer without PFTase. (D) EIC 
chromatogram (m/ z = 499.99) of 17a after 2.5 min irradiation at 800 nm 
(Ti:sapphire laser, 210 mW, 90 fs) in the presence of PFTase, showing the 
formation of farnesylated peptide 19a. 
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caged peptides including those containing multiple cysteines, with no risk of caging 
group migration. 
 
Figure 2-5 Live-cell experiments showing temporal control of enzymatic 
palmitoylation via NDBF-thiol caging. (A) Images obtained by fluorescence 
confocal microscopy illustrating intracellular localization of fluorescently labeled 
peptide 20 in SKOV3 cells, before (top) and after (bottom) UV exposure. (B) 
Quantification of colocalization of peptide and membrane dye via Pearson’s 
coefficient analysis, indicating a significant increase in plasma membrane 
localization of peptide upon irradiation. 
Next, light-triggered intracellular palmitoylation of caged peptide 20 was studied 
using human ovarian carcinoma SKOV3 cells. Cells were incubated with 20 in for 
3 h at 37 °C to allow cellular uptake. The cells were then divided into two groups 
and one was subjected to 5 min of UV irradiation at 330 nm. Both irradiated and 
non-irradiated cells were incubated for an additional 120 min at 37 °C, stained with 
nuclear and membrane markers and imaged by confocal microscopy. As observed 
in the fluorescence microscopy images (Figure 2-5A), before irradiation, the 
peptides reside primarily in the cytosol and Golgi. However, after UV exposure, the 
peptides trafficto the plasma membrane where they colocalize with the membrane 
dye; this change in colocalization occurs due to enzymatic palmitoylation. The 
degree of colocalization of the peptide and plasma membrane dye was quantified 
61 
 
by calculating Pearson’s coefficients for both the non-irradiated (0.26) and 
irradiated cells (0.76) which clearly indicates a significant increase in membrane 
localization of the peptide after irradiation (Figure 2-5B). It is important to note that 
while all of the peptide did not localize to the membrane upon photolysis, this is 
unlikely to be due to incomplete uncaging since UV-mediated uncaging is quite 
fast and efficient (see Figure 2-3). In their original work, Draper et al.46 reported 
incomplete localization even when starting with the fully deprotected form of the 
peptide used here.46 Similar results (only partial localization in pulse-chase 
labeling experiments) have been reported in work with fluorescent proteins that 
are prenylated and palmitoylated and have been attributed to competing pathways 
involving degradation versus membrane targeting.49 
To study the localization process in more detail, samples of the caged peptide were 
allowed to internalize for 3 h and then uncaged by UV exposure. Analysis of the 
cellular distribution of the peptide in those samples at different times ranging from 
30 to 120 min showed that the membrane colocalization reached a peak after 30 
min followed by a slow decrease (Figure S18). Such behavior is consistent with 
observations made with fluorescent proteins that have been shown to undergo 
dynamic cycling involving palmitoylation and concomitant membrane localization 
followed by depalmitoylation and internaliza- tion.50,51 Overall, these live cell 
experiments illustrate how NDBF caging of cysteine allows an enzyme substrate 
for palmitoylation to be temporally activated, thus permitting the processes of 
cellular entry and subsequent enzymatic modification to be deconvoluted. 
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Finally, in order to highlight the improved uncaging efficiency of NDBF and its utility 
in live cell experiments, a comparison was made between the uncaging efficiency 
of NDBF versus the 6-nitroveratryl (NV) group which is one of the most frequently 
used caging groups.15 We elected to study this experimentally since a range of 
values for the quantum yield of NV have been reported.15 Thiol-protected forms 
of Fmoc-Cys-OMe were prepared using the two caging groups which were then 
subjected to UV irradiation (365 nm) and the extent of deprotection was monitored. 
Uncaging data obtained by HPLC analysis shown in Figure S19, shows that the 
NDBF uncaging efficiency is greater than 10-fold higher than that of NV. This 
difference reflects the high molar absorptivity (ε = 15 300 M−1 cm−1) and high 
quantum yield (Φ = 0.2) of NDBF leading to a high εΦ (∼3060) value versus that 
of NV (εΦ ≈ 6000 × 0.01 = 60).52 Thus, the lower uncaging efficiency manifested 
by NV requires longer irradiation times to obtain comparable levels of uncaging. 
When SKOV3 cells were subjected to 50 min of irradiation (10-fold longer than was 
used to uncage 20), a significant decrease in cell viability was observed. Figure 
S20 shows a 5% loss of viability after 5 min of irradiation and a 57% decrease after 
50 min. Clearly this excessive loss of viability precludes the use of NV protection 
in this experiments and serves to underscore the increased efficiency and utility of 
NDBF. However, it should be noted that the two-photon action cross-section of 
NDBF thiol uncaging is comparable to those manifested by Bhc- carboxylates31 
and NDBF-alcohols.36 To date, two-photon activation of such caged molecules has 
been restricted to experiments where only a small fraction of uncaging is required 
to obtain a biological response. At present, it is unclear whether a large fraction of 
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an NDBF-caged bioactive thiol can be released via two-photon excitation in cells 
since longer irradiation times may result in IR heating or phototoxicity; cell-based 
experiments to answer these questions are currently in progress. Nevertheless, 
the results reported here highlight the utility of NDBF caging for a variety of different 
biological applications. Coupled with its utility for the synthesis of peptides 
containing multiple cysteines, the data described here make it clear why NDBF is 
a superior choice for thiol caging. 
2.3 CONCLUSION 
 
In this work, we analyzed the photolysis of several Bhc- protected thiol-containing 
peptides and small molecules. Those experiments revealed that Bhc-caged thiols 
exhibit variable uncaging yields and that their photolysis frequently leads to the 
formation of an unwanted rearrangement product. Using NMR analysis, the 
structure of the photochemically produced isomer was established to be a 4-
methylcoumarin-3-yl thioether. 
The poor uncaging yield of Bhc-caged thiols led us to search for a more efficient 
thiol caging group that would be useful for biological applications; accordingly, 
NDBF caging, which has previously been shown to be effective for hydroxyl group 
protection, was explored. NDBF-protected Fmoc-cysteine was synthesized and 
successfully incorporated into a K-Ras-derived peptide via standard solid-phase 
synthesis. The resulting caged peptide was photolyzed and completely converted 
to free peptide with a photolysis quantum yield of 0.2. The two- photon action 
cross-section of the caged peptide was measured to be 0.13 GM at 800 nm 
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comparable to that of Bhc-OAc. The one- and two-photon photolysis of a caged K-
Ras peptide in the presence of PFTase revealed that the free peptide formed upon 
irradiation is efficiently converted by the enzyme to its biologically relevant 
prenylated form. The NDBF-protected cysteine was also used to develop a light-
activatable, cell- penetrating peptide containing a caged and a farnesylated 
cysteine. Confocal microscopy analysis showed that the caged peptide could be 
activated inside cells upon light exposure which resulted in intracellular migration 
due to enzymatic palmitoylation. Taken together, this work for the first time reports 
an efficient, robust, and broadly applicable strategy for the synthesis of a variety 
of peptides and related small molecules containing caged thiols that can be 
activated by both one- and two-photon processes in live cells. These results set 
the stage for a variety of studies where spatiotemporal control of thiol reactivity is 
required, including a diverse span of applications ranging from chemical biology to 
material science. 
2.4 Experimental Section 
 
General Details. All reagents needed for SPPS were purchased from Peptide 
International (Louisville, KY). All other solvents and reagents used for synthesis 
and other experiments were purchased from Sigma-Aldrich (St. Louis, MO). High-
performance liquid chromatography (HPLC) analysis (analytical and preparative) 
was performed using a Beckman model 125/166 instrument, equipped with a UV 
detector and C18 columns (Varian Microsorb-MV, 5 μm, 4.6 × 250 mm and 
Phenomenex Luna, 10 μm, 10 × 250 mm, respectively). 1H NMR data of synthetic 
compounds were recorded at 500 MHz on a Varian Instrument at 25 °C. 1H NMR 
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data for the products of photolysis reactions were recorded using a Bruker 
Advance III 700 MHz spectrometer with 1.7 mm TCI cryoprobe. 
General Procedure for Solid-Phase Peptide Synthesis (SPPS). Peptides were 
synthesized using an automated solid-phase peptide synthesizer (PS3, Protein 
Technologies Inc., Memphis, TN) employing Fmoc/HCTU-based chemistry. Fmoc-
Met-Wang resin (0.25 mmol) was transferred into a reaction vessel, and peptide 
chain elongation was performed using HCTU and N-methylmorpho- line. Standard 
amino acid coupling was performed by incubation of 4 equiv of both HCTU and 
Fmoc-protected amino acid with the resin for 30 min. Coupling of Fmoc-Cys(Bhc)-
OH or Fmoc-Cys(NDBF)-OH was performed by incubation of 1.5 equiv of both the 
amino acid and HCTU with the resin for 6 h. Peptide chain elongation was 
completed by N-terminus deprotection using 10% piperidine in DMF (v/v). 5-Fam 
coupling was conducted by incubation of 1.2 equiv of 5-Fam, 1.2 equiv of HCTU, 
and 2 equiv of N,N-diisopropylethylamine (DIEA) with the resin for 8 h. Resin was 
then transferred into a syringe filter, washed three times with DCM, and dried in 
vacuo. Global deprotection and resin cleavage were accomplished via treatment 
with Reagent K. Peptides were then precipitated with Et2O and pelleted by 
centrifugation, and the residue was rinsed twice with Et2O. The resulting crude 
peptide was dissolved in MeOH and purified by preparative reversed-phase (RP)-
HPLC. 
General Procedure for Synthesis of Peptides Containing C-Terminal Methyl 
Esters. Trityl chloride resin (1 equiv) was transferred into a fitted syringe and 
washed three times with DMF. In a separate flask, Fmoc-Cys-OMe (3 equiv) was 
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treated with DIEA (6 equiv) in DCM, transferred into the resin-containing fitted 
syringe, and then mixed overnight using a rotisserie. Resins were treated with 
MeOH to cap any unreacted trityl moiety, followed by washing three times with 
DMF. The prepared Fmoc-Cys-OMe-loaded resins were used to synthesize 
peptides containing C-terminal methyl esters via traditional Fmoc/HCTU-based 
chemistry as described in “General Procedure for Solid-Phase Peptide Synthesis”. 
5-Fam-KKKSKTKC(Bhc)VIM (5): ESI-MS calcd for [C87H126BrN16O23S2 + 3H]3+ 
635.2597, found 635.2568.  
5-Fam-KKKSKTKC(NDBF)VIM (17b): ESI-MS calcd for [C91H130N17O23S2 + 3H]3+ 
630.9650, found 630.9658.  
C(Bhc)VLS: ESI-MS calcd for [C27H37BrN4O9S+ H]+ 673.1537, found 673.1575. 
Dansyl-GC(Bhc)VLS: ESI-MS calcd for [C41H51BrN6O12S2 +H]+ 963.2363, found 
963.2302. 
Dansyl-GC(NDBF)VLS: ESI-MS calcd for [C45H55N7O12S2 + Na]+ 972.3248, found 
972.3280. 
KKKSKC(Bhc)CVIM (5): ESI-MS calcd for [C63H109BrN15O17S3 + 3H]3+ 507.5485, 
found 507.5497. 
Fmoc-Cys(MOM-Bhc)-OCH3 (3). Chloride 2 (93 mg, 0.28 mmol) and Fmoc-Cys-
OCH3 (200 mg, 0.56 mmol) were dissolved in 3 mL of a solution of 2:1:1 
DMF/CH3CN/H2O/0.1% TFA (v/v). Zn(OAc)2 was then added (154 mg, 0.70 
mmol) and the reaction monitored by thin-layer chromatography (TLC) (1:1 
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Hex/EtOAc). After 2 days, the solvent was removed and the reaction purified via 
column chromatography (1:1 Hex/EtOAc) to give 149 mg of 3 as a yellow powder 
(81% yield): 1H NMR (CDCl3) δ 7.83 (1H, s) 7.76 (2H, d, J = 7.5), 7.6 (2H, d, J = 
7.5 Hz), 7.38 (2H, m), 7.29 (2H, m), 7.13 (1H, s), 6.36 (1H, s), 5.74 (2H, s), 4.68 
(1H, m), 4.38−4.48 (2H, m), 4.20 (1H, t), 3.74 (3H, s), 3.50 (3H, s); HR-MS (ESI) 
m/z calcd for (C31H28BrNO8S + Na)+ 676.0611 (79Br) and 678.0596 (81Br), found 
676.0639 (79Br) and 678.0636 (81Br). 
Fmoc-Cys(MOM-Bhc)-OH (4). Ester 3 (100 mg, 0.15 mmol) and Me3SnOH (69 
mg, 0.38 mmol) were dissolved in CH2Cl2 (5 mL) and brought to reflux. After 7 h 
the reaction was judged complete by TLC (1:1 Hex/EtOAc). The solvent was 
removed in vacuo and the resulting oil redissolved in EtOAc (20 mL). The organic 
layer was washed with 5% HCl (3 × 10 mL) and brine (3 × 10 mL), dried with 
Na2SO4, and evaporated to give 92 mg of 4 as a yellow powder (90% yield): 1H 
NMR (d6-acetone) δ 8.12 (1H, s), 7.86 (2H, d, J = 7.5), 7.73 (2H, t, J = 7), 7.41 
(2H, t, J = 7.5), 7.33 (2H, m), 7.16 (1H, s), 6.42 (1H, s), 5.64 (1H, s), 5.42 (2H, s), 
4.51 (1H, b), 4.37−4.41 (2H, m), 4.32 (1H, t), 4.25 (1H, t), 4.07 (2H, d), 3.49 (3H, 
s); HR-MS (ESI) m/z calcd for [C30H26BrNO8S + Na]+ 662.0455 (79Br) and 664.0439 
(81Br), found 662.0472 (79Br) and 664.0428 (81Br). 
Fmoc-Cys(NDBF)-OCH3 (15). NDBF-Br (1.00 g, 3.12 mmol) and Fmoc-Cys-
OCH3 (2.2 g, 6.25 mmol) were dissolved in 60 mL of a solution of 2:1:1 
DMF/ACN/0.1% TFA in H2O (v/v/v). A 0.5 M aqueous solution of Zn(OAc)2 was 
prepared in 0.1% TFA (v/v), and 25 μL of that solution was added to the reaction 
mixture. The reaction was monitored by TLC (1:1 Hex/Et2O) and stopped after 36 
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h of stirring at room temperature. Solvent was evaporated in vacuo, and the final 
product was purified via column chromatography (1:1 Hex/ Et2O) to give 0.90 g of 
a diastereomeric mixture of 15 as a yellow oil (48% yield): 1H NMR (CDCl3) δ 
8.38−8.40 (1H), 8.01−8.06 (2H, m), 7.77 (2H, m), 7.54−7.63 (4H, m), 7.30−7.45 
(5H, m), 5.58−5.59 (1H, m), 4.84−4.88 (1H, m), 4.53−4.59 (1H, m), 4.14−4.40 (3H, 
m), 3.72−3.78 (3H), 2.84−3.03 (2H, m), 1.72−1.74 (3H, m); HR-MS (ESI) m/z calcd 
for [C33H28N2O7S + Na]+ 619.1515, found 619.1537. 
Fmoc-Cys(NV)-OMe. This compound was synthesized following the same 
procedure described above for synthesis of 15, except NDBF-Br was replaced with 
1-(bromomethyl)-4,5-dimethoxy-2-nitrobenzene (NV-Br, 80% yield): 1H NMR 
(CDCl3) δ 7.78 (2H, d, J = 7.5), 7.68 (1H, s), 7.62 (2H, t, J = 8.0 Hz), 7.42 (2H, t, J 
= 7.5 Hz), 7.33 (2H, t, J = 8 Hz), 6.89 (1H, s), 5.66 (H, d, J = 8.0 Hz), 4.64 (1H, q, 
J = 7.5 Hz), 4.42 (2H, d, J = 7.0 Hz), 4.25 (1H, t, J = 7.5 Hz), 4.00 (3H, s), 3.94 
(3H, s), 3.81 (3H, s), 3.00 (2H, m); HR-MS (ESI) m/z calcd for [C28H28N2O8S + Na]+ 
575.1464, found 575.1493. 
Fmoc-Cys(NDBF)-OH (16). Ester 15 (900 mg, 1.50 mmol) was dissolved in 25 mL 
of CH2Cl2, and Me3SnOH (678 mg, 3.75 mmol) was added. The reaction was 
refluxed for 7 h and monitored by TLC (1:1 Hex/EtOAc), at which point the solvent 
was removed in vacuo and the resulting oil dissolved in EtOAc (30 mL). The 
organic layer was washed with 5% HCl (3 × 10 mL) and brine (3 × 10 mL), dried 
with Na2SO4, and evaporated to give 786 mg of 16 as a yellow powder (90% yield) 
as a diastereomeric mixture: 1H NMR (CDCl3) δ 8.36− 8.39 (1H), 7.97−8.03 (2H, 
m), 7.75−7.77 (2H, m), 7.53−7.62 (4H, m), 7.30−7.42 (5H, m), 5.58−5.62 (1H, m), 
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4.88−4.91 (1H, m), 4.54−4.66 (1H, m), 4.16−4.40 (3H, m), 2.88−3.04 (2H, m), 
1.71− 1.74 (3H, m); 13C NMR (CDCl3) δ 174.42, 158.28, 155.88, 153.66, 147.66, 
143.75, 141.31, 133.37, 129.45, 128.95 127.73, 127.11, 125.21, 123.77, 122.41, 
121.87, 120.99, 119.97, 112.18, 108.25, 67.49, 53.48, 47.02, 39.60, 33.70, 23.66; 
HR-MS (ESI) m/z calcd for [C32H26N2O7S + Na]+ 605.1358, found 619.1335. 
General Procedure for UV Photolysis of Caged Molecules. The caged 
compound was dissolved in photolysis buffer (50 mM phosphate buffer (PB), pH 
7.4 containing 1 mM DTT) at a final concentration of 25−250 μM. The solutions 
were transferred into a quartz cuvette (10 × 50 mm) and irradiated with 365 nm UV 
light using a Rayonet reactor (2 × 14 W RPR-3500 bulbs). After each reaction the 
samples were analyzed by RP-HPLC or liquid chromatography−mass 
spectrometry (LC-MS). 
General Procedure for LC-MS Analysis. Aliquots (100 μL) containing 5−20 μM 
caged compound in photolysis buffer were irradiated in a Rayonet UV photoreactor 
or using an 800 nm laser (see below for description). Each irradiated sample was 
then analyzed by LC-MS. The general gradient for LC-MS analysis was 0−100% 
H2O (0.1% HCO2H) to CH3CN (0.1% HCO2H) in 25 min. 
Photolysis Study of Bhc-Protected Boc-Cysteamine (11) and NMR Analysis 
of the Photoisomerization Reaction. Aliquots (200 μL) containing compound 11 
(200 μM in photolysis buffer) were irradiated at 365 nm for 80 and 400 s. After 
each illumination, samples were analyzed via RP-HPLC by monitoring the 
absorbance at 220 nm. To obtain sufficient photoisomer for NMR analysis, 10 mL 
of a 300 μM solution of 11 was irradiated for 6 min and purified via preparative RP-
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HPLC. The collected eluate was lyophilized to yield ∼1 mg of the desired 
compound, which was then dissolved in 500 μL of d6-acetone and subjected to 1H 
NMR analysis. 
Photolysis Rate and Quantum Efficiency of 17b Using UV Excitation. Aliquots 
(100 μL) containing 17b (200 μM in photolysis buffer) were irradiated at 365 nm in 
a Rayonet UV reactor. The duration of irradiation ranged from 5 to 90 s. After each 
irradiation interval, 80 μL of the sample was analyzed by RP-HPLC. The reaction 
samples were eluted with a gradient of 0.1% TFA in H2O (Solvent A) and 0.1% 
TFA in CH3CN (Solvent B) (gradient of a 3% increase in Solvent B/min, flow rate 
1 mL/min) and monitored by fluorescence (λex = 492 nm, λem = 518 nm). Reaction 
progress data were plotted in KaleidaGraph 3.0 and fitted via nonlinear 
regressional analysis to a first-order process. The quantum efficiency (Qu) was 
calculated using the formula Qu =(Iσt90%)−1, where I is the irradiation intensity in 
einstein cm−2 s−1, σ is the decadic extinction coefficient (103 × ε, molar extinction 
coefficient) in cm2 mol−1, and t90% is the irradiation time in seconds for 90% 
conversion to the product.31 The UV intensity of the lamps (I) in the photoreactor 
was measured using potassium ferrioxalate actinometry.37 
Laser Apparatus for Two-Photon Irradiations. The light source that was utilized 
for two-photon irradiation is a home-built, regeneratively amplified Ti:sapphire 
laser system. This laser operates at 1 kHz with 210 mW pulses centered at a 
wavelength of 800 nm. The laser pulses have a Gaussian full width at half-
maximum of 80 fs. Samples were irradiated in a 15 μL quartz cuvettes (Starna 
Cells Corp.). 
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Two-Photon Uncaging Cross-Section (δu) of 17a at 800 nm. The two-photon 
action cross-section for 17a was measured by comparing the photolysis rate of 
17a with that of Bhc-OAc as a reference (δu = 0.45 at 800 nm). Aliquots (100 μL) 
containing 17a (300 μM in photolysis buffer) were irradiated with the 800 nm laser 
system for varying amounts of time, ranging from 2.5 to 30 min. Each sample was 
analyzed by HPLC using the method described above. Similar photolysis 
experiments were conducted using 100 μL aliquots of Bhc-OAc (100 μM in 50 mM 
PB, pH 7.2). Photolyzed Bhc-OAc solutions were also analyzed by RP-HPLC. The 
compounds were eluted with a gradient of Solvent A and Solvent B (gradient of a 
1% increase in Solvent B/min, flow rate 1 mL/min) and monitored by absorbance 
at 220 nm. Reaction progress data were analyzed as described above, and the 
first-order decay constants for the two compounds were used in the formula 
δuΦu(17a)= δuΦu(reference) × Kobs(17a)/Kobs(reference) to calculate the value 
of δu for 17a, where δuΦu(reference) = 0.45 GM. 
UV- and Two-Photon-Triggered Farnesylation of 17. A 7.5 μM solution of 
compound 17 was prepared in prenylation buffer (15 mM DTT, 10 mM MgCl2,50 
μM ZnCl2, 20 mM KCl, and 22 μM FPP) and divided into three 100 μL aliquots. 
Yeast PFTase was added to the first aliquot to give a final concentration of 30 nM, 
but the resulting sample was not subjected to photolysis. The second aliquot was 
irradiated in the absence of yeast PFTase, while the third sample was 
supplemented with yeast PFTase (50 nM) and then photolyzed with either UV or 
laser light. UV photolysis was conducted for 1 min at 365 nm, while two-photon 
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irradiation was performed for 2.5 min at 800 nm. Each sample was incubated for 
30 min at room temperature and then analyzed by LC-MS as described above. 
Cell Culture and Microscopy. SKOV3 cells were grown in Mcoy’s 5a medium 
containing 10% FBS at 37 °C under CO2 (5.0%). For microscopy experiments, 
cells were seeded into 35 mm glass-bottomed dishes at a density of 8 × 103 
cells/cm2. To monitor the trafficking of 20 before and after UV irradiation inside 
cells, SKOV3 cells were incubated with 5 μM 20 for 3 h. The medium was then 
replaced with RPMI (10% FBS) medium without phenol red. Half of the plates were 
irradiated at 330 nm for 5 min using a transilluminator (Fotodyne Inc.), and then all 
of the plates were incubated for 120 min at 37 °C under CO2 (5.0%). Cells were 
then incubated with Hoecht 33342 (2 μg/mL) and AF488-WGA (15 μg/mL) in 
Mcoy’s 5a (10% FBS) medium for 10 min. The medium was removed, and cells 
were washed three times with warm phosphate-buffered saline (PBS), followed by 
RPMI medium (10% FBS, no phenol red). Cells were directly imaged using an 
Olympus FluowView IX2 inverted confocal microscope with a 60× objective. 
Colocalization of the peptide with the plasma membrane, in the presence and 
absence of UV exposure, was statistically quantified using Pearson correlation 
coefficient analysis calculated using FIJI software. 
Cell Viability Assay. SKOV3 cells were grown and irradiated for 0,5, and 50 min 
following the same procedure described above. In each sample, medium was 
replaced with 1 mL of Mcoy’s 5a medium (10% FBS) containing 0.5 mg/mL 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and incubated for 1 h 
at 37 °C under CO2 (5.0%). Medium was removed from each plate, and cells were 
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washed once with warm PBS. Next, 1.5 mL of DMSO was added to each plate to 
lyse the cells. The cells were placed on an orbital shaker for 15 min until they were 
completely dissolved. Absorbance was obtained at 570 nm using a UV 
spectrometer. Data were normalized such that cells that were not exposed to 
irradiation had a cell viability of 100%.  
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3 6-Bromo-7-hydroxy-3-methyl coumarin (mBhc) is an 
efficient multi-photon labile protecting group for thiol 
caging and three-dimensional chemical patterning 
 
3.1 Introduction 
Photo-removable protecting groups (also known as caging groups) allow spatio-
temporally controlled release or activation of a variety of biomolecules, including 
peptides and inhibitors inside living systems.1,2 These protecting groups can be 
used to mask specific functionalities present in bioactive agents (generating caged 
inactive molecules) such that they can be cleaved on-demand upon irradiation and 
release the bioactive species.3,4 Recent advances in the development of two-
photon cleavable protecting groups allow uncaging using near IR irradiation 
instead of UV light, with remarkably improved spatial resolution and increased 
penetration while causing significantly lower photo-toxicity.5,6 This has broadened 
the application of the caging strategy for photo-triggered release of biomolecules 
inside tissues or organisms useful for a variety of biological studies.7 Additionally, 
two-photon uncaging approaches have proved to be extremely useful for creating 
novel biomaterials; in that strategy, laser irradiation is used to unmask a specific 
caged functionality pre-incorporated into a hydrogel or matrix, such that it can be 
used to immobilize peptides, proteins or cells in a three dimensionally controlled 
fashion.8–10 Such highly tuned matrices allow artificial extracellular environments 
to be created that can be used to study cell migration, differentiation and cell-cell 
interactions.11  
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Differences in the chemical reactivity of various functional groups means that there 
is no single protecting group that can be universally employed for caging 
applications.1 Sulfydryl-containing compounds play critical roles in various aspects 
of cellular function.12,13 Hence, significant effort has gone into development of 
photo-activatable thiol-containing peptides or small molecule substrates as tools 
to elucidate or dissect cellular pathways;14,15 under many conditions, thiols are the 
most reactive nucleophiles present in biological systems. Importantly, they are 
prone to oxidation and are also relatively poor leaving groups compared with 
phosphates and carboxylates.16 Those features render the design of 
photoremovable thiol protecting groups challenging.  
Ortho-nitrobenzyl (ONB) compounds are the most commonly used caging groups 
for sulfhydryl-protection.17 ONB groups provide free thiols in high yield upon 
photolysis, however, they are poor chromophores and they generally lack two-
photon sensitivity. To address these limitations, coumarin-based protecting groups 
have been utilized due to their high one- and two-photon sensitivity. The 
fluorogenic character of coumarins can also be used as a tool to track the caged 
probes inside cells, tissue or in a polymeric matrix.18 Despite several reports that 
showed successful application of brominated hydroxy-coumarin (Bhc, 1) for thiol-
protection,9,19,20 a recent study showed photolysis of Bhc-protected thiols often 
leads to the generation of unwanted photo-isomeric by-products.21 The two-step 
mechanism of this photo-rearrangement process was studied in detail by Distefano 
and coworkers, which set the stage for further modification of the Bhc structure to 
engineer reduced photoisomerization. 
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In this report, guided by mechanistic studies of the photo-triggered isomerization 
of Bhc-thiols, we developed 6-bromo-7-hydroxy-3-methyl coumarin-4-ylmethyl 
(mBhc, 3) as an alternative coumarin-based caging group that can afford efficient 
thiol release upon one- and two-photon irradiation. To test the efficiency of mBhc 
for thiol-protection in peptides, we have synthesized an mBhc-protected form of 
cysteine (Fmoc-Cys(mBhc)-OH) suitable for incorporation via solid phase peptide 
synthesis and subsequently used it to prepare a K-Ras-derived peptide. One- and 
two-photon photolysis of the caged peptide resulted in clean conversion to the free 
compound with no photo-isomerization. Irradiation of the caged peptide using a 
near-IR laser in the presence of an enzyme (protein farnesyltransferase, PFTase) 
resulted in the generation of a free thiol-containing peptide which was then 
enzymatically farnesylated. To further evaluate the utility of this novel caging group 
for biomaterial applications, an mBhc-protected thiol was covalently incorporated 
into a hydrogel. Using a 740 nm two-photon laser from a confocal microscope, 
patterns of free thiols were generated inside the matrix and visualized by reaction 
with maleimide functionalized fluorophores. Such 3D patterns could be useful for 
a variety of applications in tissue engineering.10,11  
 
Scheme 3-1 Coumarin-based caging groups discussed in this work. 
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3.2 Results and Discussion 
 
3.2.1 Design and synthesis of a coumarin-based caging group for efficient 
thiol protection 
 
In previous work, we demonstrated that the major product of photolysis of Bhc-
protected thiols (4) is not the free thiol, but rather an isomeric product (6) that is 
formed via the two step process illustrated in Scheme 3-2. We proposed that the 
first step of that mechanism involves a photo-induced 1,3 shift of the thiol from the 
exocyclic position to the endocyclic 3 position yielding intermediate 5 that 
undergoes tautomerization to produce the final photo-rearranged product 6. Those 
results illustrate why Bhc is not an efficient caging group for thiol protection. To 
address this limitation, we have reported nitrodibenzofuran (NDBF) as an 
alternative caging group for thiol protection, which showed remarkably high 
uncaging efficiency in both one- and two-photon processes.21 
Despite the efficiency of NDBF for thiol caging, using coumarin-based caging 
groups for thiol protection is still advantageous due to their comparatively 
straightforward synthesis, higher water solubility (relative to NDBF) and the 
fluorogenic character of coumarin which is useful to track probes inside cells. 
Hence, we elected to investigate the development of an alternative coumarin-
based caging group for thiol protection in small molecules and peptides.  
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Scheme 3-2 Photo-rearrangement mechanism of Bhc protected cysteine.   
 
We initially hypothesized that changing the substituents on the phenolic ring of Bhc 
could be used to decrease the extent of photo-rearrangement over uncaging. 
Therefore, we decided to study the photolysis of a thiol protected by 
hydroxycoumarin (Hc, 2, Scheme 1) lacking the bromine on the phenolic ring. 
Hence, Hc-protected Boc-cysteamine (7, Figure 3-1A) was synthesized following 
a previously reported procedure22 and  studied as a model caged thiol for 
photolysis experiments. Solutions of compound 7 in buffered aqueous solution 
were irradiated using 365 nm light for varying times. Analysis of the photolysis 
reactions via LC-MS using extracted ion current data (EIC) clearly indicates the 
formation of the undesired photo-isomer upon photolysis as evidenced by the 
appearance of a new peak (tR = 7.71 min) with an m/z ratio identical to that of the 
starting material (Figure 3-1B, C); no Hc-OH (9, m/z = 231) generation was 
observed in the corresponding EIC chromatogram suggesting minimal uncaging 
occurred upon irradiation.  
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In addition to these data, it should be noted that Kotzur et al. previously reported 
photo-rearrangement occurring upon photolysis of 7-amino and 7,8-
bis(carboxymethoxy) coumarin protected thio-carbamates.19 These results and 
observations indicate that photoisomerization is widespread in coumarin 
Figure 3-1 Photolysis reaction of Hc-protected Boc-cysteamine. (A) Structures 
used in this study.  (B) EIC chromatogram (m/z = 334.09, calcd for [M(7)-tBu+K]+ 
= 334.01) of a 50 µM solution of 7 in photolysis buffer (50 mM phosphate buffer, 
pH 7.4 containing 1 mM DTT) before irradiation, (C) EIC chromatogram (m/z = 
334.09, calcd for [M(7)-tBu+K]+ = 334.01) of a 50 µM solution of 7 in photolysis 
buffer after 6 min irradiation at 365 nm, this data clearly indicates generation of 
the photo-isomer, (D) EIC chromatogram (m/z = 231.01, calcd for [M(9) +K]+ of 
7 after 6 min irradiation showing no evidence of generation of 9, this indicates 
photolysis leads predominantly to photo-isomerization rather than uncaging. 
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photochemistry and that simple alteration of the substituents on the phenolic ring 
would not be sufficient to shut down the photoisomerization reaction manifold. 
Given those results, we next elected to modify the endocyclic 3 position which is 
directly involved in the photo-rearrangement mechanism. We hypothesized that 
replacing the hydrogen atom at that position with an alkyl moiety should attenuate 
photo-isomerization due to several factors. First, the presence of an alkyl group on 
C-3 would block photoisomer formation since intermediate 12 cannot re-aromatize 
due to the absence of a hydrogen at the 3 position. Second, the syn pentane type 
interaction between the sulfur and the C-3 methyl group shown in Scheme 3-3 
should make it sterically more difficult for the sulfur atom to migrate to the C-3 
position. Computational analysis of the model compounds mBhc-SCH3 and Bhc-
SCH3 shows that the lowest energy conformers for both molecules position the 
thiomethyl group 90° out of the coumarin plane (see Figure S1). However, the 
steric hindrance noted above is highly destabilizing for mBhc-SCH3 as evidenced 
by the large increase in conformational energy that occurs when the thiomethyl 
group is moved towards the coumarin plane; such a movement would be required 
in the thiol migration step. 
Based on this hypothesis, we decided to synthesize 6-bromo-7-hydroxy-3-methyl 
coumarin-4-ylmethyl bromide (mBhc-Br, 3a) and examine its utility for thiol 
protection, particularly for S-protection of cysteine containing peptides. The 
synthesis of mBhc-Br is depicted in Scheme 3-4. Dropwise addition of Br2 to an 
ice cold solution of ethyl-2-methylacetoacetate in CHCl3 followed by overnight 
stirring at room temperature gave 4-bromo-2-methylacetoacetate (14, 70% 
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yield).23 That compound was subsequently treated with 4-bromoresorcinol in 
CH3SO3H overnight at room temperature to afford the desired bromide (3a) in 35% 
yield. After successful synthesis of mBhc-Br, we next sought to utilize this caging 
group for thiol protection in cysteine containing peptides to evaluate its uncaging 
efficiency in the context of biologically useful molecules.   
Our strategy for creating caged peptides was to prepare mBhc-protected Fmoc-
Cys-OH and incorporate that into a peptide of interest through solid phase peptide 
synthesis (SPPS). The synthesis of the desired mBhc S-protected cysteine 
suitable for SPPS is illustrated in Scheme 3-4. The phenolic hydroxyl group of 
mBhc was protected as a MOM ether via treatment with MOM-Cl and TEA to give 
compound 15 in 95% yield. That species was then used to alkylate Fmoc-Cys-
OCH3 under mild acidic conditions using Zn(OAc)2 as a catalyst to produce 16 in 
90 % yield. The resulting methyl ester was hydrolyzed via treatment with 
(CH3)3SnOH 24 in refluxing CH2Cl2 to generate a caged form of Fmoc-cysteine 
(Fmoc-Cys(mBhc)-OH 17) in 85 % yield.  
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Scheme 3-3 Illustration of potential effects of C-3 substitution on 
photoisomerization process. 
 
 
Scheme 3-4 Synthesis of Fmoc-Cys(mBhc)-OH and its incorporation into a K-Ras-
derived peptide via SPPS. 
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Synthesis of the desired caged peptide was performed via SPPS, in which Fmoc-
protected amino acids were added sequentially to the growing chain anchored on 
Wang resin. Standard coupling conditions were used throughout the synthesis 
except for the incorporation of Fmoc-Cys(mBhc)-OH where the coupling time was 
increased to 6 hours to ensure quantitative incorporation. Final acidic treatment of 
the resin-bound peptide with Reagent K ensured removal of all side-chain 
protecting groups including the MOM group present on the mBhc moiety, and 
cleavage of the peptide from the resin to produce the desired caged molecule. The 
above procedure was successfully used to generate a caged form of a K-Ras-
derived peptide (18) that was subsequently used to study the uncaging reaction 
and the utility of this new protecting group. 
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Figure 3-2 Uncaging studies using a peptide with a mBhc-protected thiol. (A) 
Photo-triggered uncaging of mBhc-protected K-Ras peptide (18). (B) EIC 
chromatogram (m/z = 520.57, calcd for [M + 3H]3+= 520.58) of a 100 µM 
solution of 18 before irradiation, (C) EIC chromatogram (m/z = 520.57, calcd 
for [M + 3H]3+= 520.58) of a 100 µM solution of 18 after 60 s irradiation at 365 
nm suggesting that no photo-isomer is generated and only the remaining 
starting peptide peak is present, (D) EIC chromatogram (m/z = 647.37, calcd 
for [M + 2H]2+= 647.37) of a 100 µM of 18 after 60 s irradiation at 365 nm 
which clearly indicates formation of free peptide 19. 
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After synthesis and purification of the mBhc S-protected peptide, photolysis 
experiments were carried out to probe for the formation of free peptide and any 
possible photo-isomer. Thus, a solution of 18 was irradiated using 365 nm light 
and subsequently analyzed by LC-MS. As confirmed by the extracted ion-current 
(EIC) data shown in Figure 3-2, photolysis resulted in the generation of the desired 
uncaged peptide as evidenced by the appearance of the corresponding peak with 
the expected mass (tR = 0.75 min, m/z = 647). However, apart from the remaining 
caged peptide peak (18, m/z = 520), there was no evidence of any new peak 
bearing the same mass suggesting that no photo-isomer was generated upon 
photolysis. Photolysis experiments were carried out in presence of 1mM DTT to 
block possible disulfide formation, thus simplifying analysis of the crude reaction 
mixture. (see Figure S2). Similar photolysis experiments, previously reported by 
our group using the analogous Bhc-protected (lacking the methyl group at C-3) 
peptide, resulted in the photo-isomer being the predominant product with only low 
amounts of the desired uncaged peptide formed. Overall, the data presented here 
indicates that an mBhc caged thiol, unlike its Bhc-protected counterpart, 
undergoes clean conversion to the uncaged peptide with no significant formation 
of undesired photo-rearranged byproducts. 
3.2.2 Photo-physical properties of an mBhc protected thiol 
 
The observations noted above suggest that mBhc should be useful as a caging 
group for thiol protection in peptides and other biomolecules. Accordingly, the 
spectral and photochemical properties mBhc were studied in detail in order to 
compare them with Bhc and other established caging groups. Perusal of the data 
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summarized in Table 3-1 shows that λmax(ex) and λmax(em) of mBhc at pH 7.2, are 
minimally (~ 5 nm) red-shifted relative to those of Bhc due to the electronic effect 
of the methyl substituent. The molar absorptivity of mBhc was measured to be 
14,500 M-1cm-1 which is comparable to that of Bhc. The one- and two-photon 
uncaging efficiencies of an mBhc -protected thiol were also quantified by irradiating 
solutions of 18 followed by analysis via RP-HPLC (Figure 3-3). For one-photon 
measurement, solutions of 18 were irradiated using 365 nm light in a Rayonet 
reactor for varying amounts of time ranging from 5 to 60 sec and analyzed by RP-
HPLC to monitor the disappearance of 18 over time. The one-photon quantum 
yield for thiol uncaging of 18 was measured to be 0.01 by following the 
disappearance of caged peptide over different irradiation times and using 6-bromo-
7-hydroxycoumarin-4-ylmethyl acetate (Bhc-OAc) as a reference, which was 
photolyzed under the same conditions (Fig 3B). In order to fully evaluate the photo-
conversion yield of mBhc protected thiols to the free thiols, a fluorophore-labeled 
homolog of the caged peptide 18 (Figure S4) and also an mBhc-protected form of 
cysteamine (Figure S3) were prepared. Having the fluorophore group remain 
associated with the thiol moiety after photolysis allowed us to fully monitor the 
release of the free thiol or any other possible byproducts using analytical RP-HPLC 
via fluorescence detection That HPLC data shows essentially clean conversion of 
the caged compounds to the corresponding free thiols with no photo-isomer or 
byproduct formation. Further experiments were carried out to evaluate the two-
photon uncaging efficiency of mBhc. For those measurements, solutions of 18 
were irradiated at 800 nm using a pulsed Ti:Saphire laser and the photolysis 
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products were again analyzed by RP-HPLC and confirmed by LC-MS (Figure 3-
3C). The two-photon action cross-section of mBhc was measured to be 0.16 GM 
at 800 nm again using Bhc-OAc as a reference. The two-photon action cross-
section and quantum yield for mBhc are comparatively high considering that thiols 
are poorer leaving groups relative to carboxylates and phosphates. 
 
 
Table 3.1 Photophysical properties of mBhc-thiol versus Bhc-OAc. 
 
  λmax 
(ex)  
(nm) 
λmax (em) 
(nm) 
ɛ (λmax) 
(M-1cm-1) 
Qu (365 
nm) 
δu (800 
nm) 
mBhc-thiol 
(18) 
374  480 14,500 0.01 0.16 
Bhc-OAc  370  474 15,000 0.04 0.42 
λmax (ex) and λmax (em):  absorption and emission maximum in nm, 
respectively, ɛ: extinction coefficient in M-1cm-1 at wavelength indicated, Qu: 
quantum yield of one-photon uncaging at 365 nm, δu two-photon action cross-
section in 10-50cm4s/photon (GM) for uncaging at 800 nm. 
Figure 3-3 Photophysical properties of mBhc. (A) Absorption and emission 
spectra of mBhc (3) in 50 mM PB, pH 7.4. (B) Time course of photolysis of 18 and 
Bhc-OAc as a reference at 365 nm and (C) Time course of photolysis of 18 and 
Bhc-OAc as a reference at 800 nm (pulsed Ti:Saphire laser, 210 mw, 80 fs pulse 
width) quantified by RP-HPLC. Photolysis reactions were performed in 100 µM 
(for UV), and 300 µM (for TP) solutions of 18 containing 1 mM DTT in 50 mM PB, 
pH 7.4. 
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3.2.3 One- and two-photon activation of protein prenylation  
 
Since an mBhc protected thiol demonstrated good uncaging efficiency toward one- 
and two-photon excitation, we next sought to study its utility for photo-triggered 
activation of a peptide in a more biologically relevant context. Protein prenylation 
is a ubiquitous post-translational modification that plays critical roles in a variety of 
cellular functions including the regulation of cell growth, differentiation and 
cytoskeletal integrity. Prenylation involves the enzymatic attachment of a prenyl 
group through a thioether linkage to a conserved cysteine residue near the C-
terminus of various proteins.25 This process is catalyzed by protein 
prenyltransferases including protein farnesyltransferase which transfers a farnesyl 
(C15) group. Among the proteins that undergo prenylation is Ras, which upon 
farnesylation migrates to plasma membrane where it participates in key cell 
signaling pathways including cell division. Mutations in the Ras protein have been 
linked to numerous types of cancers.26  
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To investigate the utility of mBhc, the K-Ras derived peptide described above was 
studied in in vitro prenylation reactions. It should be noted peptide 18 incorporates 
an mBhc-protected cysteine residue at the natural site of prenylation and hence 
should not be a substrate for protein farnesyltransferase in its caged state. 
However, upon irradiation, photo-cleavage of the protecting group should generate 
a peptide manifesting a free thiol suitable for prenylation by PFTase (see Figure 3-
3A). To test this, in vitro farnesylation reactions using the caged K-Ras derived 
peptide 18 were performed under several different conditions. As predicted, 
Figure 3-4 Photo-triggered farnesylation of an mBhc-protected K-Ras peptide. (A) 
Structures of peptides and products relevant to this study. (B) EIC chromatogram 
(m/z = 520.65, calcd for [M + 3H]3+= 520.58) of a 7.5 µM solution of 18 in a 
prenylation buffer containing PFTase with no irradiation. (C) EIC chromatogram 
(m/z = 647.45, calcd for [M + 2H]2+= 647.39) of a 7.5 µM solution of 18 after 60 s 
irradiation at 365 nm in prenylation buffer without PFTase showing the formation 
of free peptide 19. (D) EIC chromatogram (m/z = 500.06, calcd for [M + 3H]3+= 
499.99) of a 7.5 µM of 18 after 60 s irradiation at 365 nm in presence of PFTase 
showing the formation of farnesylated peptide 21. 
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incubation of the caged peptide with the enzyme and FPP did not result in the 
generation of any farnesylated peptide. LC-MS analysis of the mixture indicates 
only the presence of the caged peptide (m/z = 520.65, Figure 3-3B). Photolysis of 
18 for 60 seconds at 365 nm in the absence of the enzyme, produced the free-thiol 
containing peptide (19) as evidenced by the appearance of a new peak with a 
lower retention time exhibiting the expected mass (m/z = 647.45). Importantly, 
photolysis of 18 in the presence of PFTase resulted in generation of a different 
peak corresponding to the expected farnesylated peptide (21). This was confirmed 
by the detection of a new peak eluting at 5.36 min with an m/z ratio of 500.06 which 
is in good agreement with the calculated value (m/z for [M+3H]3+ = 499.99).  
Since, photo-triggered activation of the mBhc-protected peptide was successful 
using a one-photon (UV) process, we next sought to further evaluate its ability to 
be uncaged via two-photon excitation where IR light is used as the trigger in lieu 
of UV irradiation. This would open the door for employing such caged peptides in 
studies performed inside tissue or whole organisms where UV light has low 
penetration and causes phototoxicity. Accordingly, in vitro farnesylation 
experiments, similar to those described above for UV irradiation, were carried out 
using an 800 nm laser light source. Irradiation of 18 using 800 nm laser light for 5 
min in the absence of PFTase resulted in the generation of free peptide (Figure 
S5). However, two-photon irradiation of caged peptide in the presence of FPP and 
PFTase generated the farnesylated peptide as confirmed by LC-MS analysis 
(Figure S5). This data clearly illustrates that mBhc-protected K-Ras peptide can 
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be being activated and undergo farnesylation upon near IR irradiation, setting the 
stage for future studies in whole cells and tissue samples.  
3.2.4 Two-photon patterning using a mBhc-caged thiol  
 
In addition to their use for triggering biological activity as noted above, caged thiols 
are also useful for creating patterns of thiols that can be further functionalized for 
various material science applications. In particular, since the above experiments 
demonstrated that mBhc could be efficiently removed by two-photon excitation with 
800 nm light, we reasoned that it should be possible to use an mBhc-protected 
thiol to create 3D patterns within a hydrogel matrix. This has been previously 
accomplished using a Bhc-protected thiol.9,27 However, the improved efficiency of 
thiol-uncaging obtained with mBhc relative to Bhc due to elimination of the 
photoisomerization pathway should increase the utility of this approach; in theory, 
higher levels of thiol uncaging should be obtained with mBhc for a given amount 
of irradiation. Accordingly, we sought to compare the thiol patterning obtained 
using mBhc versus Bhc. Hyaluronic acid (HA) hydrogels were modified with mBhc- 
or Bhc-protected thiols by coupling mBhc/Bhc-protected cysteamine with the 
carboxylate groups of HA, and furan functional groups, which are crosslinked with 
poly(ethylene glycol) (PEG)-bismaleimide (Scheme 3-5, Figure 3-5A). Unreacted 
furan groups are quenched with N-hydroxyethyl maleimide and then the 
functionalized, crosslinked hydrogels are extensively washed. The resulting 
material was then infused with sulfhydryl-reactive AlexaFluor546-maleimide to 
allow visualization of any uncaged thiols formed followed by two-photon irradiation 
at 740 nm using a confocal microscope.  Square tile patterns were created by 
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scanning a square region of interest 5-20 times in the x-y plane at a fixed z-
dimension. The overall dimensions for each square tile were 80x80 µm, with the 
plane of the patterned tile positioned 150 µm from the base of the hydrogel. After 
uncaged thiols react with the Alexa Fluor reagent, the patterns were imaged and 
quantified by confocal microscopy. Images from those experiments (Figure 3-5B) 
illustrate how clean patterns can be prepared using this approach. As expected, 
the intensity of thiol labeling was greater in hydrogels prepared using mBhc 
compared with Bhc due to the greater uncaging efficiency of the former. 
Quantitative image analysis of the immobilized Alexa Fluor 546 dye (Figure 3-5C) 
shows that the uncaging efficiency of the mBhc-functionalized hydrogel is 
approximately 4-fold higher than that obtained using the Bhc-containing material. 
Overall, these results further highlight the utility of the mBhc group for thiol 
protection. 
 
Scheme 3-5 Schematic representation of (A) synthesis of mBhc and Bhc protected 
cysteamine, followd by (B) conjugation to HA-carboxylic acids using DMT-MM prior 
to crosslinking HA-furan with PEG-bismaleimide. 
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Figure 3-5 Comparison of two-photon patterning using Bhc- and mBhc-caged 
thiol. (A) Bhc or mBhc to is conjugated to HA-carboxylic acids using DMT-MM prior 
to crosslinking HA-furan with PEG-bismaleimide. (B) Schematic representation of 
two-photon patterning in Bhc or mBhc-conjugated HA hydrogels. A 3D hydrogel 
scaffold (i) is formed when Bhc/mBhc-modified HA-furan is chemically crosslinked 
with PEG-bismaleimide (ii).. The resulting photo-labile hydrogel undergoes 
photolysis of the Bhc/mBhc groups using two-photon irradiation to liberate free 
thiols in discrete regions of the hydrogel, which then react with maleimide-bearing 
Alexa Fluor 546 (mal-546) (iii)  (C) Visualization of mal-546 patterns in the x-y 
plane and z-dimension in mBhc and Bhc conjugated HA hydrogels. Regions of 
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interest were scanned 5 to 20 times at a fixed z-dimension. The concentrations of 
mBhc and Bhc were matched based on UV absorbance. Patterns in mBhc and 
Bhc conjugated HA hydrogels were imaged at different confocal settings due to 
Bhc patterns being so faint in comparison to mBhc patterns. (D) The z-axis profile 
of immobilized mal-546 in mBhc and Bhc conjugated HA hydrogels was quantified 
with the maximum intensity was centered at 0 μm. 
3.3 Conclusion 
In this work, we have developed mBhc as an alternative, coumarin-based caging 
group capable of mediating thiol photo-release through both one- and two-photon 
irradiation. The design of mBhc was guided by recently reported mechanistic 
experiments that showed that photo-isomerization of Bhc-caged thiols leads to a 
low uncaging yield. Studies of the spectral properties of mBhc show minimal 
variations from those of Bhc suggesting that mBhc should be a useful 
chromophore with high fluorogenic character. A form of mBhc [Fmoc-Cys(MOM-
mBhc)-OH] suitable for solid phase synthesis was prepared and used to assemble 
a K-Ras derived peptide incorporating a caged cysteine residue. One-photon 
photolysis of the caged peptide at 365 nm resulted in clean conversion to the free 
peptide with a photolysis quantum yield of 0.01. The two-photon action cross-
section of the caged peptide was also measured to be 0.13 GM at 800 nm, 
comparable to that of Bhc-OAc. The one-and two-photon uncaging of the caged 
peptide in the presence of PFTase and FPP generated a farnesylated peptide 
indicating that the free peptide which resulted from photolysis can be recognized 
by PFTase and become enzymatically modified. The high two-photon uncaging 
efficiency of mBhc protected thiols was also harnessed to create 3D patterns of 
thiols inside hydrogels for material science applications. Overall, this work sets the 
stage for future work requiring caged sulfhydryl groups. Given the unique reactivity 
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of thiols, the mBhc protecting group developed here should be useful for a variety 
of applications in biology and material science. 
3.4 Experimental Section 
General. All reagents needed for solid phase peptide synthesis were purchased 
from Peptide International (Louisville, KY). All other solvents and reagents used 
for synthesis and other experiments were purchased from Sigma Aldrich (St. Louis, 
MO) or Caledon  Laboratory Chemicals (Georgetown, ON, Canada). Lyophilized 
sodium hyaluronate (HA) was purchased from Lifecore Biomedical (2.15 x 105 
amu) (Chaska, MN, USA). Dimethyl sulfoxide (DMSO), 4-(4,6-dimethoxy-1,3,5-
triazin-2-yl)-4-methylmorpholinium chloride (DMT-MM), 1-methyl-2-pyrrolidinone 
(NMP), furfurylamine, and Dulbecco’s phosphate buffered saline (PBS) were 
purchased from Sigma-Aldrich (St. Louis, MO, USA). N-(2-hydroxyethyl)maleimide 
was purchased from Strem Chemicals (Newburyport, MA, USA). 2-(N-
mortholino)ethanesulfonic acid (MES) were purchased from BioShop Canada Inc. 
(Burlington, ON, Canada). Dialysis membranes were purchased from Spectrum 
Laboratories (Rancho Dominguez, CA, USA). Alexa Fluor 546 maleimide (mal-
546) was purchased from Thermo Scientific (Waltham, MA, USA). HPLC analysis 
(analytical and preparative) was performed using a Beckman model 125/166 
instrument, equipped with a UV detector and C18 columns (Varian Microsorb-MV, 
5 µm, 4.6 x 250 mm and Phenomenex Luna, 10 µm, 10 x 250 mm respectively). 
1H NMR data of synthetic compounds were recorded at 500 MHz on a Varian 
Instrument at 25 °C, unless noted. 13C NMR data of synthetic compounds were 
recorded at 125 MHz on a Varian Instrument at 25 °C, unless noted. 
96 
 
Procedure for solid phase peptide synthesis. Peptides were synthesized using 
an automated solid-phase peptide synthesizer (PS3, Protein Technologies Inc., 
Memphis, TN) employing Fmoc/HCTU based chemistry. The synthesis started by 
transferring Fmoc-Met-Wang resin (0.25 mmol) into a reaction vessel followed 45 
min swelling in DMF. Peptide chain elongation was performed using HCTU and N-
methylmorpholine. Standard amino acid coupling was carried out by incubation of 
4 equiv of both HCTU and the Fmoc protected amino acid with the resin for 30 min. 
Coupling of Fmoc-Cys(MOM-mBhc)-OH (17) was performed by incubation of 1.5 
equiv of both the amino acid and HCTU with the resin for 6 h. Peptide chain 
elongation was completed by N-terminus deprotection using 10% piperidine in 
DMF (v/v). Global deprotection and resin cleavage was accomplished via 
treatment with Reagent K. Peptides were then precipitated with Et2O, pelleted by 
centrifugation and the residue rinsed twice with Et2O. The resulting crude peptide 
was dissolved in CH3OH and purified by preparative RP-HPLC. 
KKKSKTCC(mBhc)IM (18). ESI-MS: calcd for [C67H115BrN16O17S2 + 2H]2+ 
780.3698, found 780.3777. 5-Fam-KKKSKTKC(mBhc)VIM calcd for 
[C88H125BrN16O23S2+2H]2+ 959.3937, found 959.3782. 
 
Hc-Boc-cysteamine (7). 7-hydroxycoumarin bromide (1a, 1 g, 3.9 mmol), N-(tert-
butoxycarbonyl)aminoethanethiol (10, 0.86 mL, 5.1 mmol) and 1,8-
diazabicyloundec-7-ene (0.76 mL, 5.1 mmol) were dissolved in 70 mL of THF and 
refluxed for 4 h. The reaction was judged completed by TLC (2:3, Hexanes/EtOAc). 
Solvent was removed in vacuo, and the crude mixture was diluted in 75 mL EtOAc. 
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The organic layer was washed with 50 mL of 0.1 M NH4Cl(aq), brine, and then dried 
over Na2SO4. The solvent was removed in vacuo and the crude mixture was 
purified via silica gel chromatography (2:1 Hexanes/EtOAc) to give 836 mg of 7 as 
a yellow oil (61 % yield). 1H NMR (d6-acetone) δ 7.79 (1H, d, J = 8.4 Hz), 6.95 (1H, 
dd, J = 8.75, 2.8 Hz), 6.32 (1H, s), 3.95 (2H, s), 3.37 (2H, q, J = 6.3 Hz), 2.74 (2H, 
t, J = 7 Hz), 1.54 (9H, s). 
Ethyl 4-bromo-2-methyl acetoacetate (14). Compound 14 was prepared by 
minor modification of a published procedure.23 To an ice cold solution of ethyl 2-
methylacetoacetate (2 mL, 14 mmol) in 50 mL CHCl3 was added a solution of Br2 
(0.68 mL, 14 mmol) in 10 mL CHCl3 over 15 min. The mixture was then warmed to 
rt and stirred overnight. The organic layer was then washed with 50 mL solution of 
0.1 M sodium thiosulfate, brine and then dried over Na2SO4. The solvent was 
evaporated in vacuo to yield 2.34 g of 14 as a pale orange oil (75 % yield). The 
resulting material was directly used for the next step without further purification.  
6-Bromo-7-hydroxy-3-methyl coumarin-4-ylmethyl bromide (mBhc-Br, 3a). A 
solution of 4-bromoresrocinol (1 g, 5.3 mmol) and ethyl 4-bromo-2-methyl 
acetoacetate 14 (2.3 g, 10.4 mmol) in 30 mL of CH3SO3H was stirred at rt 
overnight. The mixture was then fractionated between 100 mL H2O and 100 mL 
EtOAc. The organic layer was separated, washed with brine and dried over 
Na2SO4. Solvent was removed in vacuo and the resulting crude mixture was 
purified via silica gel chromatography (2:1, Hexanes/EtOAc) to give 645 mg of 3 
as a pale yellow solid. 1H NMR (d6-acetone) δ 8.01 (1H, s), 6.95 (1H, s), 4.85 (2H, 
s), 2.21 (3H, s). 13C NMR (d6-acetone) δ 160.81, 156.32, 153.12, 143.73, 128.59, 
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121.46, 111.94, 106.00, 103.45, 24.14, 11.98. HR-MS (ESI) m/z calcd for 
[C11H7Br2O3]- 346.8720, found 346.8720. 
MOM-mBhc-Br (15). To a stirred solution of 3a (400 mg, 1.15 mmol) and 
chloromethyl methyl ether (MOM-Cl, 0.13 mL, 1.72 mmol) was added 1,8-
diazabicyloundec-7-ene (0.19 mL, 1.3 mmol). The mixture was stirred for about 2 
h until complete as judged by TLC (in CH2Cl2). The solvent was evaporated in 
vacuo. The resulting crude material was dissolved in a small amount of CH2Cl2 
which was then loaded onto a silica gel column and purified to give 428 mg of 3 as 
pale yellow oil (95 % yield). 1H NMR (CDCl3) δ 7.82 (1H, s), 7.15 (1H, s), 5.31, 
(2H, s), 4.62 (2H, s), .352 (3H, s), .228 (3H, q, J = 6.3 Hz), 13C NMR (CDCl3) δ 
161.40, 155.55, 152.80, 142.50, 128.03, 123.26, 113.33, 108.66, 103.96, 95.21, 
56.64, 37.09, 12.91.  HR-MS (ESI) m/z calcd for (C13H12Br2O4 + Na)+ 414.8980, 
found 414.9001. 
mBhc-cysteamine (23). mBhc-Br (3a, 0.8 g, 2.3 mmol), N-(tert-
butoxycarbonyl)aminoethanethiol 10 (0.51 mL, 3.0 mmol) and 1,8-
diazabicyloundec-7-ene (0.45 mL, 3.0 mmol) were dissolved in 50 mL of THF and 
refluxed for 4 h. The reaction was judged completed by TLC (2:3, Hexanes/EtOAc). 
The solvent was removed in vacuo, and the crude mixture was diluted in 50 mL 
EtOAc. The organic layer was washed with 50 mL of 0.1 M NH4Cl(aq), brine, and 
then dried over Na2SO4. The solvent was removed in vacuo and the crude mixture 
was purified via silica chromatography (2:1 Hexanes/EtOAc) to give 664 mg of 
mBhc-Boc-cysteamine as a yellow oil. The purified compound was dissolved in 10 
mL solution of CH2Cl2:TFA (1:1) and stirred for 30 min. The mixture was 
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evaporated and purified via silica (1:1 Hex/EtOAc) to give 514 mg (65 % yield) of 
the desired free amine as white solid. 1H NMR (d6-acetone) δ 7.92 (1H, s), 6.77 
(1H, s), 6.32 (1H, s), 4.06 (2H, s), 3.29 (2H, q, J = 6.3 Hz), 3.02 (2H, t, J = 7 Hz), 
2.19 (3H, s), 13C NMR (D2O) δ 163.53, 155.54, 151.78, 139.08, 128.88, 124.15, 
113.36, 106.72, 103.38, 49.95, 48.31, 34.24, 13.52. HR-MS (ESI) m/z calcd for 
(C13H14BrNO3 + H)+ 343.9951, found 414.9827. 
 
Fmoc-Cys(MOM-mBhc)-OCH3 (16).  Bromide 15 (400 mg, 1 mmol) and Fmoc-
Cys-OCH3 (714 mg, 2 mmol) were dissolved in 10 mL of a solution of 2:1:1 
DMF/CH3CN/H2O/0.1% TFA (v/v/v/v).  Zn(OAc)2 was then added (550 mg, 2.5 
mmol) and the reaction monitored by TLC (1:1 Hexanes/EtOAc).  After two days, 
the solvent was removed and the reaction purified via column chromatography (1:1 
Hexanes/EtOAc) to give 530 mg of 16 as yellow powder (81% yield). 1H NMR 
(CDCl3) 7.80 (1H, s), 7.72 (2H, t, J=8), 7.59 (2H, t, J=7), 7.32-7.40 (2H, m), 7.28 
(2H, t, J=7), 7.11 (1H, s), 5.61 (1H, d, J=6.5), 5.28 (2H, s), 4.53 (1H, t, J=7), 4.45 
(1H, t, J=7), 4.22 (1H, t, J=6.5), 3.70-3.80 (6H, m), 3.51 (3H, s), 3.16 (1H, q), , 2.20 
(3H, s). 13C NMR (CDCl3) δ 170.81, 161.41, 155.74, 155.32, 152.69, 143.67, 
143.59, 143.53, 141.35, 141.31 128.57, 127.79, 127.76 127.11, 127.05, 125.01, 
124.96, 122.31, 120.02, 120.01, 114.16, 108.41, 103.79, 95.18, 67.07, 53.87, 
52.97, 47.19, 35.62, 29.83, 13.27. HR-MS (ESI) m/z calcd for [C32H30BrNNaO8S + 
Na]+ 690.0773, found 690.0720. 
Fmoc-Cys(MOM-mBhc)-OH (17).  Ester 16 (200 mg, 0.30 mmol) and 
(CH3)3SnOH (135 mg, 0.75 mmol) were dissolved in CH2Cl2 (5 mL) and brought to 
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reflux.  After 7 h, the reaction was judged complete by TLC (1:1 Hexanes/EtOAc), 
the solvent removed in vacuo and the resulting oil redissolved in EtOAc (20 mL).  
The organic layer was washed with 5% HCl (3 x 10 mL) and brine (3 x 10 mL), 
dried with Na2SO4 and evaporated to give 173 mg of 17 as a yellow powder (90% 
yield).  1H NMR (CDCl3) δ 9.68 (1H, s), 7.73 (1H, s), 7.64 (2H, t, J=7), 7.55 (2H, t, 
J=7), 7.32 (2H, t, J=7.5), 7.23 (2H, m), 6.98 (1H, s), 5.93 (1H, d, J=7.5), 5.19 (2H, 
s), 4.72 (1H, m), 4.65 (1H, t, J=7), 4.41 (1H, t, J=7), 4.16 (1H, t, J=7), 3.70-3.80 
(2H, m), 3.45 (3H, s), 3.20 (1H, m), 3.06 (1H, q), 2.14 (3H, s). 13C NMR (CDCl3) δ 
173.41, 161.83, 156.20, 155.21, 152.43, 144.06, 143.63, 143.48, 141.26, 141.22, 
128.58, 127.11, 127.06, 125.02, 119.98, 114.09, 108.52, 103.58, 95.06, 67.26, 
56.63, 53.72, 47.09, 35.51, 29.79, 14.18, 13.24, 31.07, 14.07.  HR-MS (ESI) m/z 
calcd for [C31H28BrNNaO8S + Na]+ 676.0601, found 676.0601. 
General procedure for UV photolysis of caged molecules. Solutions of caged 
compound were prepared in photolysis buffer (50 mM phosphate buffer, pH 7.4 
containing 1 mM DTT) at a final concentration of 25-250 µM. Aliquots (100 µL) of 
caged compound solutions were transferred into quartz cuvettes (10 x 50 mm) and 
irradiated for varying amounts of time with 365 nm UV light using a Rayonet reactor 
(2 x 14 watt RPR-3500 bulbs). After different irradiation times, the samples were 
analyzed by RP-HPLC or LC-MS.  
General procedure for two-photon photolysis of caged molecules. Solutions 
of caged compounds were prepared in photolysis buffer (50 mM phosphate buffer, 
pH 7.4 containing 1 mM DTT) at a final concentration of 300 µM. Aliquots (15 µL) 
of caged compound solutions were transferred into 15 µL quartz cuvettes (Starna 
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Cells Corp. dimensions: 1mm × 1mm) and irradiated using two-photon laser 
apparatus at 800 nm for varying amount of time. After each reaction the samples 
were analyzed by RP-HPLC or LC-MS. The light source utilized for two-photon 
irradiation was a homebuilt, regeneratively amplified Ti:sapphire laser system. This 
laser operates at 1 kHz with 210 mw pulses centered at a wavelength of 800 nm. 
The laser pulses have a Gaussian full width at half maximum of 80 fs. 
One-photon quantum yield (Qu) and two-photon uncaging cross-section (δu) 
of 18. Qu and δu for 18 were measured by comparing its photolysis rate with Bhc-
OAc as a reference (Qu = 0.04 at 365 nm, δu = 0.45 at 800 nm). As described 
above, aliquots containing 18 were irradiated with either a 365 nm lamp or an 800 
nm laser for varying amounts of time. Each sample was analyzed by RP-HPLC to 
monitor the disappearance of the starting caged compound over time. Similar 
photolysis experiments were conducted with Bhc-OAc solutions (100 µM for UV 
and 300 µM for IR) in 50 mM phosphate buffer, pH 7.2. Photolyzed Bhc-OAc 
solutions were also analyzed by RP-HPLC. The compounds were eluted with a 
gradient of Solvent A and Solvent B (gradient of a 1% increase in Solvent B/min, 
flow rate 1 mL/min) monitored by absorbance at 220 nm. Reaction progress data 
was analyzed as described above and the first order decay constants for the two 
compounds were used in the formula Φu or δu (18) = Φu or δu (reference) × Kobs 
(18)/ Kobs(reference) to calculate the value of δu for 18 where Φu (reference) = 0.04 
and δu (reference) = 0.42 GM. 
UV and two-photon triggered farnesylation of 18.  A 7.5 µM solution of 
compound 18 was prepared in prenylation buffer (15 mM DTT, 10 mM MgCl2, 50 
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µM ZnCl2, 20 mM KCl and 22 µM FPP, 50 mM PB buffer) and divided into three 
100 µL aliquots. Yeast PFTase was added to the first aliquot to give a final 
concentration of 30 nM but the resulting sample was not subjected to photolysis; 
the second aliquot was irradiated in absence of yeast PFTase while the third 
sample was supplemented with yeast PFTase (50 nM) and then photolyzed with 
either UV or laser light. UV photolysis was conducted for 1 min at 365 nm while 
two-photon irradiation was performed for 5 min at 800 nm.  Each sample was 
incubated for 30 min at rt and then analyzed by LC-MS as described above.  
General procedure for LC-MS analysis. Aliquots (100 µL) of caged compound 
solutions which were diluted down to 5-20 µM were analyzed by LC-MS. The 
general gradient for LC-MS analysis was 0–100% H2O/0.1% HCO2H (v/v) to 
CH3CN/0.1% HCO2H (v/v) in 25 min. 
Synthesis of mBhc- and Bhc-modified HA-furan (25 a,b). HA-furan was 
prepared as previously described.28 To synthesize HA-furan (24) modified with 
mBhc or Bhc, HA-furan was dissolved in NMP:MES (100 mM, pH 5.5) at a ratio of 
1:1 to achieve 0.50% w/v HA-furan. DMT-MM was then added (5 equiv. relative to 
free carboxylic acids) followed by the dropwise addition of a solution of mBhc or 
Bhc in DMSO (1 equiv. relative to free carboxylic acids). The reaction was stirred 
at rt in the dark for 24 h and then dialyzed against H2O:NMP:DMSO (2:1:1, v/v/v) 
for 1 d. The organic fraction of the solution was halved every 24 h for 3 days before 
being replaced with only H2O for the final 2 days and then lyophilized. The resulting 
HA-furan modified with either Bhc or mBhc was then dissolved in K2CO3 (1.0% 
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w/v, 10 eq relative to furans) for 24 h, dialyzed against H2O for 3 days, and 
lyophilized.  
 
Preparation of HA Hydrogels for Photopatterning. HA-furan-(mBhc or Bhc) was 
dissolved overnight in MES (100 mM, pH 5.5):DMSO (3:1, v/v) and mixed with an 
equal volume of a solution of bis-maleimide-poly(ethylene glycol) (mal2-PEG) 
dissolved in MES buffer (100 mM, pH 5.5). The mixture was pipetted into 96-well 
glass bottom plates and allowed to react overnight at 37 °C to form hydrogels with 
a final concentration of 2.00% HA-furan-(mBhc or Bhc) and a 1:1 ratio of 
furan:maleimide. The mBhc and Bhc concentrations in the hydrogels were 
matched based on their UV absorbance at their maximum peak intensity at 365 
nm. The unreacted furans in the hydrogel were quenched with 30 mM N-(2-
hydroxyethyl)maleimide in MES buffer (100 mM, pH 5.5)  for 24 h at rt. The N-(2-
hydroxyethyl)maleimide was washed from the gel with borate buffer (100mM, pH 
9.0) to hydrolyze any remaining maleimides, followed by extensively washing of 
the hydrogel with PBS (pH 6.8). A solution of Alexa Fluor 546 maleimide (100 µM 
in PBS pH 6.8) was then soaked into the hydrogel overnight at 4 °C and excess 
supernatant was removed prior to photopatterning. The resulting HA-furan-(mBhc 
or Bhc)/mal2-PEG hydrogels are herein described as HAmBhc/PEG and HABhc/PEG, 
respectively.   
 
Photopatterning of hydrogels. HAmBhc/PEG and HABhc/PEG hydrogels were 
photopatterned using a Zeiss LSM710 META confocal microscope equipped with 
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a Coherent Chameleon two-photon laser and a 10x objective. For patterning 
experiments, the two-photon laser was set to 740 nm with 38% power (1660 mW 
max power) and a scan dwell time of 106.83 µs/μm. Due to high non-specific 
binding of Alexa Fluor 546 maleimide in the HABhc/PEG hydrogels compared to 
HAmBhc/PEG hydrogels, unreacted Alexa Fluor 546 maleimide was not washed 
from the hydrogels. This maintained the same background fluorescence in the 
HAmBhc/PEG and HABhc/PEG hydrogels, allowing the patterns to be directly 
compared. The concentration of Alexa Fluor 546 maleimide immobilized in the 
patterns exceeded the bulk unreacted Alexa Fluor 546 maleimide solution, 
permitting the visualization of the patterns. Alexa Fluor 546 maleimide reacted with 
the uncaged thiols for 4 h prior to imaging. Patterns were imaged on an Olympus 
Fluoview FV1000 confocal microscope with x-y scans every 5 µm in the z direction. 
Imaged photopatterns were quantified using ImageJ against a standard curve of 
HA/PEG gels containing Alexa Fluor 546 maleimide at different concentrations. 
The background concentration of unreacted Alexa Fluor 546 maleimide was 
subtracted from the concentration immobilized in the patterns. 
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4 Development of caged farnesyltransferase inhibitor 
for photo-chemical modulation of Ras-localization 
 
4.1 Introduction 
Biological transformations occur in a highly spatio-temporally controlled manner 
throughout the lifetime of a cell, organism or a living animal. In order to study such 
complexity, reagents that can selectively switch off (or on) certain pathways at any 
time or any place inside living systems are needed.1,2 Development of photo-
activatable bioagents such as inhibitors provide a great tool to address these 
questions. In this approach, a key functionality in a bioactive molecule is masked 
via a photo-cleavable protecting group also called caging group. Upon irradiation, 
the caging group cleaves of and results in liberation of active bio-agent. Recent 
advances in development of two-photon sensitive protecting groups allows using 
longer wavelength infra-red light, which enables photo-activations inside tissues, 
enhances uncaging resolution, and reduces photo-toxicity.3–5 These unique 
features led to development of several caged molecules which have been used for 
probing various enzymatic reactions and cellular properties. 
Ras proteins, which belong to the family of small GTPases, involve in cellular 
signal transduction.6 This signaling pathway play critical roles in various cellular 
properties including proliferation, differentiation and morphology.7–9 Studies have 
shown misregulation in Ras activity, often caused by mutation, links to various 
types of disease including cancer.10 Proper functioning of Ras requires these 
proteins to be post-translationally modified via protein farnesyltransferase 
(PFTase) enzyme. Therefore, several PFTase inhibitors that many of which are 
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commercially available (e. g. compound 1), have been developed to block 
prenylation as a mean to target cancer cells expressing oncogenic Ras.11 Given 
the critical role of Ras protein and PFTase enzyme, it would be useful to develop 
caged PFTase inhibitors that enables spatio-temporal control of Ras signaling. 
This enables probing the timing of Ras-mediated signal, as well as studying the 
effect of local inhibition of Ras within a group of cells, on cellular migration, 
differentiation and morphology.  
Previous studies have shown alkylation of the sulfhydryl group present in 1 
significantly reduces the binding affinity of the drug by disrupting the interaction 
between the sulfur and Zn (II) on the PFTase active site.12 Hence, in order to 
develop a caged photo-activatable inhibitor, we elected to alkylated the sulfhydryl 
functionality using a photo-cleavable protecting group, so that upon irradiation the 
thiol functionality become unmasked and restore the activity of the inhibitor. We 
elected to use nitrodibenzofuran (NDBF) as the caging moiety since our previous 
reports demonstrate its high one- and two-photon efficiency for thiol protection.13 
Here, we first describe the synthesis and photo-chemical properties of caged 
farnesyltransferase analogue, NDBF-FTI (2). We then demonstrate that this 
reagent can release the free FTI upon UV irradiation inside cells, which inhibits 
Ras farnesylation, localization and ultimately Ras-signaling. Finally, we showed 
that NDBF-FTI can be uncaged via two-photon irradiation in a highly spatially 
controlled manner which results in creation of defined patterns of inhibited cells 
among non-affected cells. This development sets the stage for probing effect of 
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spatio-temporal inhibition of Ras-mediated signaling not only in cell culture, but 
also in organisms and ultimately in animals.  
 
 
Scheme 4-1 Farnesyltransferase inhibitor (FTI, 1) and caged FTI (NDBF-FTI, 2). 
4.2 Result and Discussion 
 
4.2.1 Synthesis and Photo-chemical Properties of Caged FTI  
 
To prepare caged FTI analogue, NDBF-Br was initially synthesized following a 
previously reported procedure,13 and was subsequently used to alkylated the FTI 
under mild acidic condition in presence of Zn(OAc)2 as a catalyst. Carrying out the 
reaction in acidic condition renders the amine functionalities protonated, thus inert 
toward alkylation. The crude mixture was purified via preparatory HPLC to yield 
desired in NDBF-FTI in ~ 70 % yield (mixture of two diastereomers).  
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Scheme 4-2 Synthesis of NDBF-FTI. 
 
In order to evaluate the release of the free drug upon one- and two-photon 
irradiation, photolysis experiments were carried out and analyzed by LC-MS. For 
one photon uncaging experiment, 50 µM solution of NDBF-FTI in photolysis buffer 
(50 mM PB, pH 7.2, 1 mM DTT) was irradiated for 60 s at 365 nm, and was 
subsequently analyzed by LC-MS. LC-MC traces shown in Figure 4-1 reveals the 
disappearance of starting caged drug 2 and generation of a new peak with the 
mass of 560.2826 corresponding to the free FTI (calced = 560.2823).  
Similar photolysis experiment was carried out using 800 nm two-photon laser, 
which shows the formation of the free FTI after 5 minutes of irradiation. These data 
clearly demonstrate that the caged FTI analogue is capable of releasing the active 
drug upon both one and two-photon irradiation. 
One-photon uncaging kinetics was evaluated by irradiating solutions of 2 for 
varying periods of time followed by analysis via RP-HPLC (Figure 4-3). These 
experiments yielded a half-life of 11 seconds for NDBF-FTI in a standard Rayonet 
photoreactor (2×16W bulbs, indicating this molecule uncage as rapidly as 
previously reported for caged thiols. 
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Figure 4-2 HPLC quantification of disappearance of 2 and formation of the 
uncaged peptide (1) as a function of irradiation time at 365 nm. 
Figure 4-1 LC-MS analysis of uncaging of NDBF-FTI to form free FTI by 
irradiation at 365 nm. Crude LC-MS trace of a 20 µM solution of 2 in 50 mM 
pH 7.2, A) before irradiation and B) after 90s irradiation. These results clearly 
show disappearance of NDBF-FTI (m/z calcd for ([M + H]+ 799.3405, found 
735.3411) and appearance of free FTI ([M + H]+ 560.2823, found 560.2826). 
C) MS/MS of pure 2, D) MS/MS of 1 produced from UV photolysis 
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4.2.2 Photo-triggered Release of FTI Inside Cells and Modulation of Ras 
Localization  
 
The caged drug was designed for selective on-demand modulation of cellular 
properties. In order to evaluate the utility of NDBF-FTI for photo-controlled 
inhibition of farnesylation, we examined its ability for altering Ras localization inside 
live cells. To achieve this, experiments were carried out using Madin-Darby Canine 
Kidney Epithelial (MDCK) cell line which expresses H-Ras as an N-terminal GFP 
fusion (GFP-Ras). This would allow monitoring the Ras localization via 
fluorescence microscopy. Under normal condition, GFP-Ras gets farnesylated and 
localizes to plasma membrane. However, presence of FTI blocks farnesylation 
results in cytosolic accumulation of GFP-Ras. Figure 4-3 represents confocal 
microscopy images for such experiments. As expected, similar to the untreated 
cells, treatment of MDCK cells with NDBF-FTI without irradiation results in 
membrane localization of GFP-Ras proteins. However, irradiation of cells that are 
treated with NDBF-FTI for 2 min at 330 nm, results in drastic cytosolic 
accumulation of GFP-Ras, similar to the cells that are treated with free FTI.  It has 
to be noted that images were obtained 12 hours after irradiation, so that enough 
GFP-Ras get expressed and be accumulated in the cytosol and the left-over 
membrane localized GFP-Ras proteins be proteolyzed and removed from 
membrane. Control experiments in which untreated cells were irradiated for 3 min 
showed no alteration in GFP-Ras localization. These date clearly demonstrates 
the utility of NDBF-FTI for photo-controlled modulation of farnesylation inside live 
cells.  
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Successful one-photon uncaging of NDBF-FTI inside live cells, led us to test its 
ability to be activated upon longer wavelength irradiation using two-photon laser. 
This would broaden the applicability of this probe for studies inside tissues or 
organisms where UV light could not penetrate deep enough, or for experiments 
where photo-toxicity is a concern. Therefore, NDBF-FTI treated cells where 
irradiated using Nikon multi-photon microscope tuned to 700 nm. According to 
Figure 4-3 GFP-H-ras localization in MDCK cells treated with NDBF-FTI (2) 
after 330 nm irradiation. Treatments were as follows: A) Vehicle (0.2% DMSO 
(v/v)). B) 10 µM FTI (1). C) 5 µM NDBF-FTI (2), no irradiation. D) 5 µM NDBF-
FTI (2) plus 2 min irradiation. 
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confocal images shown in Fig, 1 min irradiation of cells using two-photon laser, 
resulted in inhibition of farnesylation and cytosolic accumulation of GFP-Ras.  
 
 
Figure 4-3 GFP-H-ras localization in MDCK cells treated with NDBF-FTI (2) 
after 700 nm two-photon irradiation. Treatments were as follows: A) Vehicle 
(0.2% DMSO (v/v)). B) 10 µM FTI (1). C) 5 µM NDBF-FTI (2), no irradiation. 
D) 5 µM NDBF-FTI (2) plus two-photon irradiation (300 µs/pixel). E) 5 µM 
NDBF-FTI (2) plus two-photon irradiation (300 µs/pixel), this image 
demonstrates the boundary between irradiated area and non-irradiated 
area. As expected two-photon laser NDBF-FTI can be locally uncaged in a 
group of cells, which results in creation of patterns of inhibited versus 
inhibited cells. 
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The great advantage of using laser for uncaging is that it allows spatio-temporal 
release of the drug inside cells. Figure 4-4E demonstrates a local release of FTI 
on MDCK cells showing a pattern of inhibited versus non-inhibited cells. These 
experiments demonstrate the designed NDBF-FTI is capable of spatio-temporal 
modulation of Ras mediated signal, as well as any other pathways involves 
farnesylation inside cells.  
4.3 Conclusion 
In summary, we have prepared a caged farnesyltransferase inhibitor capable of 
releasing the active inhibitor upon one- and two-photon irradiation. Unlike 
previously reported Bhc-FTI, analysis of the uncaging reactions clearly shows 
efficient release of the FTI without the formation of any unwanted byproduct. 
Cellular experiments demonstrate that the designed caged drug efficiently 
penetrates inside mammalian cells and liberates the drug upon one- and two-
photon irradiation. The released FTI inhibits farnesylation, membrane localization 
of Ras and its upstream signaling. Irradiation of the cells treated with the caged 
drug via longer wavelength two-photon laser not only allowed temporal control over 
Ras signaling, but more importantly enables highly localized inhibition in a group 
of irradiated cells. This reagent sets the stage for highly spatio-temporal 
modulation and probing of various prenylation-related pathways inside tissues or 
even whole organisms such as C. elegans, zebrafish and mice.  
4.4 Experimental Section 
114 
 
All solvents and reagents used for synthesis and other experiments were 
purchased from Sigma-Aldrich (St. Louis, MO). High-performance liquid 
chromatography (HPLC) analysis (analytical and preparative) was performed 
using a Beckman model 125/166 instrument, equipped with a UV detector and C18 
columns (Varian Microsorb-MV, 5 μm, 4.6 × 250 mm and Phenomenex Luna, 10 
μm, 10 × 250 mm, respectively). LC/MS analysis was performed employing a 
Thermo LCQ Deca ion trap mass spectrometer (Thermo Scientific, San Jose, CA) 
interfaced with an Agilent 1100 Capillary HPLC equipped with an Agilent Zorbax 
300SB-C18, 5 µm, 0.5 x 150 mm column. 1H NMR data of synthetic compounds 
were recorded at 500 MHz on a Varian Instrument at 25 °C. MDCK cells stably 
expressing GFP-H-ras were the generous gift of Dr. Mark Philips (NYU School of 
Medicine).  
Synthesis of NDBF-FTI. NDBF-Br was synthesized following a previously 
reported procedure. NDBF-Br (9.7 mg, 0.03 mmol) and FTI (10 mg, 0.01 mmol) 
were dissolved in a solution of 2:1:1 DMF/CH3CN/H2O containing 0.1% TFA (1 
mL) under a N2 atmosphere. Zn(OAc)2.6H2O was then added (30.8 mg, 0.3 mmol) 
and the reaction monitored by TLC. After overnight incubation, the solvents were 
removed and the reaction purified via HPLC using a preparative method (flow rate: 
8 mL/min, gradient: 0% solvent B, 15 min; 0-100% B in 100 min; solvent A: H2O 
and 0.1% TFA, solvent B: CH3CN and 0.1% TFA). The product eluted at 65% B 
and was then lyophilized to give 2.9 mg of a fluffy white solid in 40% yield. LC-MS 
calcd for [C40H54N4O7S + H]+ 799.3405, found 735.3411. 
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General Procedure for UV Photolysis of NDBF-FTI. The caged compound was 
dissolved in photolysis buffer (50 mM phosphate buffer (PB), pH 7.2 containing 1 
mM DTT) at a final concentration of 50 μM. The solutions were transferred into a 
quartz cuvette (10 × 50 mm) and irradiated with 365 nm UV light using a Rayonet 
reactor (2 × 14 W RPR-3500 bulbs). After each reaction the samples were 
analyzed by RP-HPLC or liquid chromatography−mass spectrometry (LC-MS).  
Laser Apparatus for Two-Photon Irradiations of NDBF-FTI. The light source 
that was utilized for two-photon irradiation is a home-built, regeneratively amplified 
Ti:sapphire laser system. This laser operates at 1 kHz with 210 mW pulses 
centered at a wavelength of 800 nm. The laser pulses have a Gaussian full width 
at half-maximum of 80 fs. Samples were irradiated in a 15 μL quartz cuvettes 
(Starna Cells Corp.). 
General Procedure for LC-MS Analysis. Aliquots (100 μL) containing 15 μM 
caged compound in photolysis buffer were irradiated in a Rayonet UV photoreactor 
or using an 800 nm laser (see below for description). Each irradiated sample was 
then analyzed by LC-MS. The general gradient for LC-MS analysis was 0−100% 
H2O (0.1% HCO2H) to CH3CN (0.1% HCO2H) in 25 min. 
Cell Culture and Microscopy. MDCK cells were grown in DMEM supplemented 
with 10% FBS at 37 °C under CO2 (5.0%). They were seeded in 35 mm glass-
bottomed dishes at the density of 2.2 x 104 cells/cm2. To carry out photo-triggered 
Ras inhibition, cells were treated with a 15 µM solution of 2 in DMEM 
supplemented with 10% FBS. After 3 h of incubation, the medium was removed, 
and cells were washed three times with warm phosphate-buffered saline (PBS), 
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followed by addition of dye-free DMEM medium (10% FBS, no phenol red). For UV 
uncaging experiment, the plates were irradiated at 330 nm for 2-5 min using a 
transilluminator (Fotodyne Inc.). Two-photon uncaging experiments were carried 
out using Nikon A1RMP microscope equipped with a Spectra Physics 15W Mai 
Tai eHP tunable IR laser, and a 20X objective. For photo-patterned inhibition, two-
photon laser was set to 700 nm with 10 % power and scan time of 200-300 µs/pixel. 
After irradiation the dye-free medium was removed and replaced with normal 
DMEM medium containing phenol red, then incubated for 12 h. Right before 
imaging, medium was again replaced with dye-free medium. Cells were directly 
imaged using an Olympus FluowView IX2 inverted confocal microscope with a 60X 
objective. 
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5 Synthesis of a nitrodibenzofuran-based caging group 
with red-shifted absorption 
 
Many of the available caging groups, particularly the ones that have used for thiol 
protection, require ultra-violet (UV) irradiation to be uncaged via one-photon 
excitation.1 This is a major constraint since UV irradiation results in major photo-
toxicity in living systems and cells. Additionally, UV light is significantly absorbed 
by endogenous biomolecules and is also scattered in tissues, which results in very 
low penetration.   
In order to overcome this problem, new caging groups with red-shifted absorption 
maxima has to be prepared. Since, nitrodibenzofuran (NDBF) has been 
successfully applied for caging variety of functionalities including thiols, we used 
that as a starting point for development of a novel caging group. Similar approach 
was previously implemented by Specht and coworkers who demonstrated that the 
addition of an electron donating substituents to biphenyl 2-(o-nitrophenyl)propen 
derivatives which are structurally similar to NDBF, not only shifts the absorption 
maxima to the longer wavelengths, but also significantly enhances the two-photon 
sensitivity to unprecedented value of 11 GM.2 Additionally, a computational study 
carried out by Knippenberg and coworkers showed derivatizing the NDBF with an 
amino group at the endocyclic C-7 position, similarly red-shifts the absorption 
absorption maxima and improves two-photon cross-section up to 15 times higher 
relative to NDBF.3  
Here we describe the synthesis of methyl 7-dimethylamino nitrodibenzofuran 
acetate (Scheme 5-1) as a new caging group with the red-shifted lambda max. The 
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compound was synthesized in 9-steps. Initial spectral studies showed λmax of 440 
nm which is 90 nm longer than that of NDBF which is 330 nm.   
 
Scheme 5-1 Nitrodibenzofuran and 7-amino nitrodibenzofuran. 
 
5.1 Results and discussion 
 
5.1.1 Synthesis of 7-amino nitrodibenzofuran (AminoNDBF) 
 
Compound 2 was prepared in a 9-step synthesis route starting from commercially 
available dibenzofuran (Scheme 5-2). Dibenzofuran (3) was acetylated using 
acetyl chloride and aluminum trichloride as a catalyst to yield 4 (73 %). The acetyl 
group was then converted to methyl acetate using diacetoxy iodobenzene 
(PhI(OAc)2) and sulfuric acid in methanol to generate methyl dibenzofuran acetate 
(5) in 95 % yield. Compound 5 was nitrated at the C-7 position via treatment with 
sodium nitrate and trifluoroacetic acid to give 6 in 80 % yield. The nitro group was 
then reduced to amine using iron powder in presence of acid under reflux to yield 
7 in 50 %. The free amine was then boc protected (8) using boc anhydride and 
base in 60 % yield. Compound 8 was brominated at the benzylic position using 
NBS and benzoyl peroxide as the radical initiator to generate 9 (90 %). The boc 
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group on compound 9 was then de-protected using TFA. The generated free amine 
was then methylated through reductive amination to generate molecule 11 in 75 
%. Compound 11 was then nitrated using nitric acid in ice cold sulfuric acid to 
generate the target molecule 2 in 75 % yield. Protonation in strong acidic condition 
renders the amine functionality an electron withdrawing group pushing the nitration 
to selectively occur at the C-3 position.  
 
Scheme 5-2 Synthesis of 7-amino nitrodibenzofuran. 
 
Spectral properties of compound 2 was measured in 50 mM PB (pH 7.2) 
demonstrating the absorption maxima to be 440 nm. This shows addition of the 
120 
 
dimethyl amino group led to a 90 nm bathochromic shift in the λmax of NDBF which 
is in correlation with our initial hypothesis and previous computational calculations 
by Knippenberg and coworkers.3 
5.2 Conclusion and future directions 
The synthesis of methyl 7-dimethylamino nitrodibenzofuran acetate (2) was 
accomplished in 9 steps. The absorption maxima of compound 2 was measured 
to be 440 nm. This clearly shows addition of the diamethyl amino group led to a 
110 nm bathochromic shift in the λmax of NDBF. It remains to be seen whether 
this molecule can be efficiently uncaged via one- and two-photon excitation. To 
test this, a caged thiol such as Fmoc-Cys-OMe has to be prepared and photolyzed 
under one- and two-photon conditions. The photolysis mixtures have to be 
analyzed via HPLC to monitor the disappearance of caged compound and 
formation of the free thiol overtime. These data will be used to evaluate the 
uncaging efficiency of 7-dimethylamino nitrodibenzofuran acetate. 
5.3 Experimental secion 
2-acetyldibenzofuran (4). This compound was synthesized following a previously 
reported procedure.4 
Methyl dibenzofuran acetate (5). Compound 5 (11.8 g, 56.2 mmol) was dissolved 
in 5 mL of CH2Cl2 and then added to 160 mL of CH3OH. While stirring, 49 mL 
(449.0 mmol) of trimethyl orthoformate (CH(OCH3)3) was added to the solution, 
followed by dropwise addition of 24 mL of H2SO4(conc.) (caution: generates heat!). 
Diacetoxy iodobenzene, PhI(OAc)2 (21.2 g, 67.4 mmol), was gradually added to 
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the reaction mixture for over 10 minutes. The mixture was stirred for 1 h and then 
the reaction judged completed by TLC (4:1 EtOAc/Hexanes). 100 mL of water was 
added to the mixture and CH3OH was removed in vacuo. Product was extracted 
using 200 mL of CH2Cl2 (highly acidic aqueous waste was neutralized by baking 
soda). The solution was washed with brine, dried over Na2SO4, and the solvent 
was removed in vacuo. The crude mixture was run through silica plug to yield 12.8 
g of 5 in 95 %. The purity of the sample was sufficient to be used for the next step. 
1H NMR (CDCl3): δ 7.94 (1H, dd) 7.56 (1H, d), 7.52 (1H, d), 7.43 (1H, m), 7.31 – 
7.38 (2H, m), 3.79 (2H, s), 3.72 (3H, s). 13C NMR: 172.23, 156.56, 155.41, 128.28, 
128.35, 127.28, 127.10, 124.57, 124.04, 122.75, 121.36, 120.74, 120.60, 52.14, 
41.06.  
Methyl 2-(7-nitrodibenzofuran-2-yl)acetate (6). Compound 5 (12.0 g, 49.9 
mmol) was dissolved in 150 mL of TFA. While stirring, sodium nitrate (4.6 g, 55.3 
mmol) was gradually added to the solution which generated dark color. The 
mixture was stirred for 1 h and the reaction was judged completed by TLC (2:3 
EtOAc/Hexanes). The reaction was quenched by adding 100 mL of water and the 
product was extracted with 150 mL of EtOAc. The organic layer was neutralized 
by 10 % NaHCO3(aq), washed with brine and dried over Na2SO4. The solution 
was evaporated. The obtained crude sample was pure enough to be used for the 
following step. In order to obtain high quality NMR, the final product was purified 
via column chromatography (1:2 EtOAc/Hexanes) to give 11.38 g of 6 as yellow 
powder in 80 % yield. 1H NMR (CDCl3): δ 8.45 (1H, d) 8.28 (1H, dd), 8.05 (1H, d), 
7.96 (1H, d), 7.61 (1H, dd), 7.51 (1H, dd), 3.82 (2H, s), 3.74 (3H, s). 
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Methyl 2-(7-aminodibenzofuran-2-yl)acetate (7). Compound 6 (10.0 g, 35.0 
mmol), Iron powder (9.8 g, 175 mmol) and ammonium acetate (18.7 g, 350 mmol) 
was suspended in 250 mL of 3:1 H2O: EtOH and refluxed for 6 h. The reaction was 
completed judged by TLC (3:1 Hexanes: EtOAc). The iron powder removed by 
filtration, EtOH removed under vacuum and the product was extracted using 100 
mL of EtOAc. The organic layer was washed with 10 % NaHCO3(aq) and Brine, 
and then dried over Na2SO4. Solvent was removed under vacuum and the final 
product was purified via column chromatography (3:1 Hexanes: EtOAc) to yield 
4.47 g of 7 as a yellow oil in 50 % yield. 1H NMR (CDCl3): δ 7.73 (1H, d) 7.68 (1H, 
d), 7.28 (1H, s), 7.24 (1H, dd), 6.85 (1H, d), 6.69 (1H, dd), 3.77 (2H, s), 3.73 (3H, 
s). 13C NMR: 172.42, 158.32, 155.14, 146.87, 128.26, 126.24, 125.20, 121.31, 
120.03, 115.40, 111.31, 111.10, 97.45, 52.10, 41.13.  
Methyl 2-(7-((boc)amino)dibenzofuran-2-yl)acetate (8). Compound 7 (2.2 g, 8.8 
mmol) was dissolved in dried DMF and cooled down to 0 °C. N,N-
Diisopropylethylamine, DIEA (3.1 mL , 17.6 mmol) was added to the solution and 
stirred for 5 min. Boc2O (8.1 mL ,35.2 mmol) was then added to the reaction 
mixture. The mixture was warmed up to room temperature and stirred for 5 h. The 
reaction completed judged by TLC (3:1 Hexanes: EtOAc). DMF was evaporated 
under vacuum and the crude mixture was taken up into 50 mL of EtOAc. The 
organic layer was then washed with brine, and dried over Na2SO4. Solvent was 
removed under vacuum. The mixture was purified via column chromatography (3:1 
Hexanes: EtOAc) to yield 2.4 g of 8 as a yellow oil in 60 % yield. 1H NMR (CDCl3): 
123 
 
δ 7.86 (2H, m) 7.50 (1H, dd), 7.35 – 7.37 (2H, m), 7.10 – 7.12 (1H, dd), 5.46 (1H, 
s), 3.77 (2H, s), 3.70 (3H, s), 1.39 (18H, s). 
Methyl 2-bromo-2-(7-((boc)amino)dibenzofuran-2-yl)acetate (9). Compound 8 
(2.4 g, 5.3 mmol) and 50 mg of benzoyl peroxide was dissolved in 50 mL of CCl4. 
The mixture was refluxed for 6 h. The reaction completed judged by TLC (2.5:1 
Hexanes: EtOAc). Reaction mixture was diluted by adding 50 mL of CH2Cl2, 
washed with 10 % NaHCO3(aq) and Brine, and dried over Na2SO4. Solvent was 
evaporated under vacuum and the resulting crude was purified via column 
chromatography (2.5:1 Hexanes: EtOAc) to give 2.56 g of 9 as a yellow solid (90 
%). 1H NMR (CDCl3): δ 7.91 (2H, m) 7.80 (1H, dd), 7.54 (1H, d), 7.39 – 7.41 (2H, 
m), 7.15 (1H, dd), 5.50 (1H, s), 3.75 (3H, s), 1.41 (18H, s). 
Methyl 2-bromo-2-(7-(dimethylamino)dibenzofuran-2-yl)acetate (11). 
Compound 9 (2.6 g, 4.7 mmol) was dissolved in 30 mL of CH2Cl2, followed by 
addition of 0.5 mL of water. 15 mL of TFA was added to the mixture and stirred for 
30 min to afford complete deprotection of the boc groups. Solvents were 
evaporated under vacuum, and the resulting crude was taken up in 30 mL of 
EtOAc. The organic layer was washed with 10 % NaHCO3(aq) and Brine, and dried 
over Na2SO4. EtOAc was removed under vacuum to give 10 in quantitative yield 
(1.5 g), which was pure enough to be used for the next step. Compound 10 (4.5 
mmol) was suspended in 80 mL of 3:1 AcOH: H2O, followed by portion-wise 
addition of sodium cyanoborohydride, NaBH3CN, (22.5 mmol, 1.4 g). The mixture 
stirred for 5 h and the reaction completed judged by TLC (2:1 Hexanes: EtOAc). 
The mixture was diluted with 100 mL EtOAc. The organic layer was washed three 
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times with saturated NaHCO3(aq) and then washed with brine. The resulting solution 
was dried over Na2SO4 and evaporated under vacuum. The crude mixture was 
purified using column chromatography (2.5:1 Hexanes: EtOAc) to yield 1.7 g of 11 
as a pale yellow oil (75 %). δ 8.16 (1H, m) 7.91 (1H, d), 7.64 (1H, dd), 7.54 (1H, 
d), 7.36 (1H, d), 7.15 (1H, dd), 5.54, (1H, s), 3.81 (3H, s), 1.4 (6H, s).  
Methyl 2-bromo-2-(7-(dimethylamino)-3-nitrodibenzofuran-2-yl)acetate (2). 
Compound 11 (1.7g, 4.7 mmol) was dissolved in least amount of THF, and was 
subsequently added to a 30 mL stirring solution of ice cold H2SO4(conc.). The 
mixture was stirred for 5 min, followed by dropwise addition of 68% v/v HNO3 (the 
solution turns dark). The mixture was stirred for 1 h. The reaction was judged 
complete by TLC (2:1 Hexanes: EtOAc). Water (60 mL) was added to quench the 
reaction, followed by addition of 60 mL of EtOAc. All the acid was neutralized by 
slow addition of NaHCO3 to the biphasic mixture (caution: generation heat and 
vigorous release of gas). The organic layer was separated, washed with brine and 
dried over Na2SO4. Solvent was evaporated under vacuum, and the obtained 
crude was purified using column chromatography (2:1 Hexanes: EtOAc) to give 
1.4 g of 2 as yellow oil (75 %). δ 8.30 (1H, s) 8.19 (1H, s), 7.83 (1H, d), 6.84 (2H, 
m), 6.30 (1H, s), 3.83 (3H, s), 3.12 (6H, s).  
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